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Thermoregulation system in mammal keeps their body temperature in a vital and yet narrow 
range of temperature by adjusting two main activities, heat generation, and heat loss. Also, these 
activities get triggered by other causes such as exercise or certain drugs. As a result, 
thermoregulation system will respond and try to bring back the body temperature to the normal 
range. Although these responses are very well experimentally explored, they often can be 
unpredictable and clinically deadly. Therefore, this thesis aims to analytically characterize the 
neural circuitry components of the system that control the heat generation and heat loss. This 
modeling approach can help us to analyze the relationship between different components of the 
thermoregulation system without directly measuring them and explain its complex responses in 
mathematical form.  The first chapter of the thesis is dedicated to introducing a mathematical 
modeling approach of the circuitry components of the thermoregulation system in response to 
Methamphetamine which was first published in [1]. Later, in other chapters, we will expand this 
mathematical framework to study the other components of this system under different conditions 
such as different circadian phases, various pharmacological interventions, and exercise. 
This thesis is composed by materials from the following papers. ‎CHAPTER 1  uses the main 
idea, model, and figures from References [1]. Meanwhile, ‎CHAPTER 2 is based on [2] 
coauthored with me and is reformatted according to Purdue University Thesis guidelines.  
Also, ‎CHAPTER 3 interpolates materials from reference [3] coauthored and is reformatted to 
comply with Purdue University Thesis guidelines. ‎CHAPTER 4 is inserted from the reference [4] 
and is reformatted according to Purdue University Thesis guidelines. Finally, ‎CHAPTER 5 is 
based on Reference [5] and is reformatted according to Purdue University Thesis guidelines. 
Some materials from each of these references have been used in the introduction Chapter.            
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 MOTIVATION AND BACKGROUND CHAPTER 1.
1.1 Motivation 
Thermoregulation systems in mammal keep their body temperature in a vital and yet narrow 
range of temperature by adjusting two main activities, heat generation, and heat loss. For 
example, as a response to the cold environment, the system signals the body to increase the heat 
production through non-shivering thermogenesis which is not related to the shivering induced 
locomotion activities. Also, the system may try to increase the body temperature via decreasing 
the heat dissipation from blood through cutaneous vasoconstriction [6]. On the other hand, to 
lower the body temperature, non-shivering thermogenesis would be shut off and excess heat is 
dissipated by increasing blood flow near the skin via cutaneous vasodilation, or through 
evaporative heat loss using the skin sweat.  
Physical activities or drugs can perturb the thermoregulation system activity in animals and 
change the body temperature to the outside of the equilibrium range. Consequently, the 
thermoregulation system signals the associated body organs for a series of heat generation or 
dissipation actions to maintain the vital range of temperature. However, sometimes the reaction 
of thermoregulation system to these perturbations is not trivial or predictable. Therefore, to learn 
more about the mechanism of these reactions, we need to observe the thermoregulation system 
outside of its equilibrium state. This allows us, for example, to measure how quickly it returns to 
the equilibrium or the pattern that the system follows back to its equilibrium. Also, we observe 
the responses of the system to other physical or chemical factors outside of the equilibrium. 
When we compare these responses to those in an equilibrium state, we can quantify certain 
properties of the thermoregulatory system.   
As mentioned, we would like to perturb the thermoregulation system and then observe its 
behavior. For example, we can achieve it by impacting the balance of certain neurotransmitters 
in the system e.g. by administrating a substance that is known to cause thermoregulation 
system’s reaction. We can also make the perturbation by physical activity or changing the 
environmental properties such as ambient temperature. In this thesis, for the first case we chose 
to inject Orexin antagonist and for the second perturbation type, we selected physical exercise, 
changing ambient temperature, and different circadian phases. 
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Dose-related temperature response to Methamphetamine (Meth) is very complicated and not 
linear. Relatively low doses of Meth (≤1 mg/kg) cause a temporary but rapid increase in body 
temperature [7]. However, as the dose of Meth increases, the dose-response curve changes in a 
non-trivial fashion. At doses between 1 and 5 mg/kg the peak temperatures do not increase but 
the temperature peak time progressively shifts to the later times: for example, the peak 
temperature for a 1 mg/kg dose (38˚C) occurs at 60 min while the peak for a 5 mg/kg dose (38˚C) 
occurs at ~180 minutes. After doses of Meth of 10 mg/kg temperature once again rapidly rises, 
peaking between 60 and 90 min, followed by a small decrease and then secondarily rises again 
remaining elevated for 5 hours after injection [7]. 
In exercise, the administration of amphetamine slows down the temperature rise (thus decreasing 
core body temperature) at the beginning of the run without affecting oxygen consumption. In 
contrast, a lower dose of amphetamine (1 mg/kg) does not change measured parameters. 
Due to non-trivial responses of thermoregulation system in mammals to exercise and 
amphetamines, it is difficult to analyze it via experiments since it is required to quantify the 
metabolism, and heat exchange between different body compartments in conscious animals.   
Therefore, in a series of publications, a set of mathematical models were constructed to 
characterize the thermoregulation system. The experimental data used to calibrate these models 
were collected from the body temperature of rats in different ambient temperatures, different 
exercise intensities, different doses of amphetamines and circadian conditions. The main 
components of these models are heat production (controlled the movement and metabolism) and 
heat dissipation (controlled by cutaneous vasoconstriction or vasodilation).  
Later in this chapter, we will describe the general model that was used to study the body 
temperature responses to Methamphetamine and how we calculate the parameters of this model. 
This model was created and developed by Molkov et al. [1]. Next, in chapter 2 we will expand 
this model to study temperature responses to methamphetamine and stress in relation to 
orexinergic neurotransmission. In chapter 3 we modify their model to unmask the impact of 
circadian variability in body temperature responses to methamphetamine. In chapter 4 we 
introduced the heat dissipation component into their model. We tried to mathematically model 
the heat exchange between core body and muscles and characterize their temperature change 
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during exercise. This development in their model helps us in chapter 5 where we aim to find how 
amphetamine impacts the mechanism of exhaustion during running. 
1.2 Background and Initial Models 
Fatal hyperthermia caused by administration of amphetamines is a typical clinical condition, yet 
for a long time we didn’t have a mathematical model explaining the etiology and pathogenesis of 
this condition. Dose dependence of temperature responses to methamphetamine is not linear and 
demonstrates a complicated and delayed pattern. Molkov et al. (2014) used mathematical 
modeling to study this phenomenon and suggested that a balanced combination of excitatory and 
inhibitory mechanisms may explain this complexity. 
Temperature responses caused by amphetamines have several phases including both hypothermic 
and hyperthermic reactions. Also, it’s seen to be dependent on ambient temperature, dose, and 
previous injections of the drug in an animal. Amphetamines evoke responses of many 
neuromediator systems. On the other hand, body temperature is controlled by multiple and 
complex neuronal circuitry mechanisms. Unfortunately, to make data interpretation more 
accessible, the majority of the researchers in this field have focused on simplified experiments, 
and therefore they often don’t have much of real-life prognostic potential. To explore and 
explain the complexity of this phenomenon we needed a mathematical or theoretical framework 
accounting for an extensive set of reported experimental facts. For this purpose, the authors in [1] 
developed a mathematical model that characterizes and explains this complex dose dependence 
of temperature responses to methamphetamine. Here I aimed to introduce their effort and 
findings. This model and some of the results will be the basis of the chapters 2 through 5.  
At room temperature (24C) Meth causes 1 to 2 C temperature increase which can take up to 
several hours depending on the injected dose. More specifically, low doses of Meth (≤ 1 mg/kg) 
evoke a rapid increase in body temperature up to approximately 38C, which can continue for 
about 2 hours (Figure ‎1.3). At higher doses, the temperature response becomes a much more 
complicated phenomenon. In fact, between doses of 1 and 5 mg/kg the temperature rises to a 
similar level but the time that the peak occurs progressively shifts. After injection of 1 mg/kg, the 
temperature rises to a maximum at between 60 to 100 minutes while after the administration of 5 
mg/kg the peak happens around 180 minutes. Surprisingly, after higher doses of Meth (≥ 10 
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mg/kg and above) temperature rapidly increases without delay and almost right after injection 
with a maximum between 60 and 90 minutes at about 39C. The peak is followed by a persisting 
high temperature up to 5 h after the injection.   
 
 
Figure ‎1.1 Experimental Data for dose-dependence temperature responses to Meth. All 
temperatures were measured 1 hour before the injections at t=0. [1]   
 
The neuronal circuitry mechanisms responsible for these responses are well explored. Recently, 
Dorsomedial hypothalamus was characterized to be a key and significant region whose activity is 
an essential factor in causing fever and stress responses [8]. Interestingly, responses to 
Methamphetamines are very similar to those induced by the activation of neurons in the 
dorsomedial hypothalamus in conscious rats. Some of these responses are such as mild 
hypertension, tachycardia, hyperthermia, and observable locomotion activity [9].  On the other 
hand, inhibition of dorsomedial hypothalamus with the administration of muscimol noticeably 
reduces responses to ecstasy which is a commonly abused derivative of amphetamine [10].  
Also, the pathways controlling such activities as thermoregulation and locomotion mediated by 
dorsomedial hypothalamus commonly include the raphe pallidus in the brainstem.  
Additionally, during the first hours after the injection of moderate doses of Meth, the temperature 
responses are weaker than the ones to the low doses of Meth. This response suggests that an 
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inhibitory component is involved in temperature response. Furthermore, if we block the 
inhibitory synaptic transmission in dorsomedial hypothalamus and raphe pallidus, we can cause 
thermogenic reactions which indicate that both regions receive inhibitory inputs [11].   
Also, inhibition provoked by Methamphetamine might be mediated by serotonergic receptors or 
inhibitory subtypes of dopaminergic receptors [12]. By introducing the model (Figure ‎1.1), 
authors translate the aggregate excitatory node (Excitation) to the dorsomedial hypothalamus 
(and other supramedullary excitatory inputs). The output of this node to the medullary node 
(Medulla) will be combined with the already explained accumulated inhibitory drive (Inhibition). 
The weighted sum of these inputs to Medulla will define its activity level. To account for the 
responses to the high doses of Meth, the high-dose node is identified as the secondary excitatory 
part of this model which doesn’t get aggregated with the inhibitory component directly. In fact, 
this node projects on the thermogenic pathway at the inframedullary sympathetic preganglionic 
(Spinal Cord) node which controls activation of thermogenesis. This activity is determined by 
the interaction between excitatory and inhibitory components whose activation depends on blood 
concentrations of Meth. Accordingly, in Figure ‎1.3 the authors described how temperature 
responses to Meth are related to the various doses. The least dose (1 mg/kg) is not large enough 
to fully activate either of Inhibitory or Excitatory nodes. 
 
 
Figure ‎1.2 Each circle in Model corresponds to a neural component which is Meth dose 
dependentt. The activity of each node is characterized by sigmoid function. [1] 
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Hence, temperature response at this dose is mostly evoked by a single excitatory multisynaptic 
pathway to Spinal Cord. At the higher dose, 3 mg/kg, Meth concentration is still not enough to 
activate the High-Dose (HD) Excitatory node; however, it is sufficient to activate the Inhibition. 
As mentioned earlier, the activity of Medulla is defined by a weighted sum of the excitatory and 
inhibitory components (Figure ‎1.3), which in this case is slightly larger than the indicator line for 
3 mg/kg. 
At 3 mg/kg, temperature doesn’t increase quickly, hence in their model the inhibitory component 
competes with the excitatory node. The balance between excitatory and inhibitory nodes, whose 
sensitivity to Meth is incrementally different, yields to a delayed respond immediately after the 
injection. However after sometimes, the blood concentration of Meth decreases at which the 
Inhibitory node keeps being active, but it is also enough to activate the excitatory component. At 
the highest dose, the High-Dose node gets activated which increases the total excitation. This 
node creates a much more significant excitatory activation in compare with supramedullary. 
Although the Excitatory node provides a similar amount of output (Figure ‎1.3), its impact on 
Spinal Cord is much more balanced off by the (negative) inhibitory component. This amount of 
excitatory outputs results in a much stronger increase in temperature at the beginning of the 
highest dose compared to what we see in lower doses. 
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Figure ‎1.3 The top plot is the Meth dose dependence activity functions of the excitatory 
and inhibitory and HD nodes in the network model. The middle plot is the activity for the 
reduced model where we only have 2 nodes (Exc and Inh). Lowest plot is the function of 
Meth concentration in blood for 4 doses of Meth including 1, 3, 5 and 10 mg/kg. [1] 
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1.3 Model construction 
The authors in [1] used the following components in the model design:  
1) The pharmacokinetics of Meth concentrations in blood after injection;  
2) A network model based on neural network whose components’ activities depend on Meth 
concentration in the blood;  
3) Finally a body temperature dynamics which is based on the output signal from each node. 
1.3.1 Pharmacokinetics Model 
Methamphetamine is absorbed very quickly from the peritoneum, and almost exponentially 
eliminated from the blood [13, 14]. Since the authors didn’t collect the data about the volume of 
the Meth distribution in blood, they used the following equations to describe the drug 
concentrations in units of mg/kg in their model: 
 
 
𝑑𝑥
𝑑𝑡
= −
𝑥
𝜏𝑎
𝑑𝑦
𝑑𝑡
=
𝑥
𝜏𝑎
−
𝑦
𝜏𝑒
 (‎1.1) 
           
where t is time in minutes, x(t) is the intraperitoneal Meth concentration and y(t) is the Meth 
concentrations in blood. This means that 𝑥/𝜏𝑎   is for drug absorption with a time constant 𝜏𝑎, 
and also 𝑦 𝜏𝑒⁄   is used for the drug elimination from the blood with a time constant of . Also, 
the initial conditions are assumed to be 𝑥(0) = 𝐷, 𝑦(0) = 0 because the administration of a dose 
D is done at time 𝑡 = 0 without any prior injection for the animal. If one solves the ODE’s in 
(‎1.1) with those initial conditions, one easily finds the analytical solution explicitly as follows:  
 
 𝑦(𝑡) = 𝐷(𝜏𝑎 𝜏𝑒⁄ − 1)
−1(𝑒−𝑡 𝜏𝑎⁄ − 𝑒−𝑡 𝜏𝑒⁄ ) (‎1.2) 
 
This model is used to describe the time dependence of Meth concentration in the blood at time t 
minutes after the injection of the particular dose.  
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1.3.2 Neural Network Model 
Per the introduction in section  1.2, the Neural network is used in the model construction to show 
the connectivity and interrelations of the neural circuitry components in the three major brain 
regions. These components are known to control the regular thermoregulatory activities in the 
rodent.  First, the excitatory part which is coming through dorsomedial hypothalamus to 
premotor sympathetic neurons in ventromedial medulla which is noted here as Medullary node. 
This excitatory node is connected to the sympathetic preganglionic region in the spinal cord 
which is shown as SPN node. In the end, the output of the SPN node defines the body 
temperature. 
As seen in [1] and other studies, the dose dependence of temperature responses to amphetamines 
is not analytically trivial which means there is no linear or simple relation that can explain it. [7, 
15-19].  
This behavior is reported on Figure ‎1.1 where after the injection of a low dose of Meth an 
immediate increase in body temperature is observed.  This response is more significant in 
magnitude than the two higher doses but smaller than the highest experimented dose. This 
response means that the activity of the inhibitory node should reduce the excitation drive in the 
system. It’s been reported that at high doses of amphetamines, they seem to be active below the 
level of the medulla [16]. Accordingly, this model assumes a second and stronger excitatory 
component that can be activated only by higher doses of Meth and hence is called HD node.    
This neural network used to create the model circuitry is shown in Figure ‎1.2 which is a simple 
feed-forward neural network. The Meth dependent activity of supramedullary excitatory node 
(Exc), Inhibitory node (Inhib) and the high-dose node HD is defined by activation (sigmoid) 
function in neural populations, 𝑃𝑖 (𝑖 = 𝐸𝑥𝑐, 𝐼𝑛ℎ𝑖𝑏, 𝐻𝐷), and is calculated using the following 
equation: 
 𝑃𝑖(𝑡) = 𝜎(𝑤𝑖 ∙ 𝑦(𝑡) + 𝛾𝑖) (‎1.3) 
 
Here   is a logistic function, and  is a used for the Meth sensitivity of each 
node for which 𝑦(𝑡) calculates the Meth concentration in blood at each given time according to 
equation (‎1.2). Finally 𝛾𝑖 defines baseline for the activity of each node 𝑃𝑖. This means that the 
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units of sensitivity parameters ( 𝑤Exc, 𝑤Inhib  ,and 𝑤HD ) are (mg/kg)
-1 
 and they have the 
dimensionless parameters 𝛾Exc, 𝛾Inhib and 𝛾HD. 
Using the projection weights of Exc and Inh nodes into Mdl, a weighted sum defines the activity 
of the Mdl as follows: 
 𝑃Mdl(𝑡) = 𝑤Exc→Mdl ∙ 𝑃Exc(𝑡) − 𝑤Inhib→Mdl ∙ 𝑃Inhib(𝑡) (‎1.4) 
 
The SPN component uses the output of Mdl and combines it with the additional excitatory input 
from HD node as the follows: 
 𝑃SPN(𝑡) = 𝑃Mdl(𝑡) + 𝑤HD→SPN ∙ 𝑃HD(𝑡) + 𝛾SPN (‎1.5) 
 
1.3.3 Temperature Model 
Finally, the activity of SPN is used to describe the change in temperature by a first-order linear 
ordinary differential equation as follows: 
 𝜏𝑇
𝑑𝑇
𝑑𝑡
= 𝑃SPN(𝑡) − (𝑇 − 𝑇0) (‎1.6) 
 
Where  is assumed to be the baseline body temperature of rodent, and T is defined as the body 
temperature in degrees Celsius, and finally time constant for the temperature response . 
Consequently, the outputs of Mdl and SPN are assumed to be in degree Celsius. 
Temperature response described in (‎1.6) has two components. These are the two main parts that 
we use later in this thesis when we construct other temperature models. These components are 
called heat production and heat dissipation of the system. Heat dissipation happens due to the 
difference between the body and an ambient temperature. According to Newton’s cooling law, 
the dissipation is proportional to the difference of the body and environment temperatures. Also, 
the heat dissipates through skin proportionally to its thermal conductivity. This term in (‎1.6) is 
inversely related to the temperature time constant 𝜏𝑇 . This conductivity correlates with the 
cutaneous blood flow. When body temperature increases, cutaneous vasodilation may increase 
thermal conductivity of the skin. At room temperature, the cutaneous vessels are known to be 
fully constricted, and Meth also has vasoconstrictive effect [10, 20, 21] thus counteracting 
potential feedback evoked by hyperthermia. Therefore, Molkov et al. assumed that the 𝜏𝑇 stays 
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constant throughout all experiments. Another important assumption was about the basal 
temperature which is defined by the basal metabolism. This baseline temperature cannot be 
decreased by any feedback mechanisms due to hyperthermia. This is a valid assumption because 
the system was studied at room temperature for which no additional heat production or 
dissipations activities are impacting the baseline metabolism. 
1.4 Conclusions 
In [1] the authors explored the complex mechanism of temperature responses to Meth based on a 
model defined by a balance of dose-dependent excitatory and inhibitory components. Some of 
the significant results are:   
1) Lethal hyperthermia can be caused by even moderate doses of Meth if the natural balance of 
these excitatory and inhibitory components is changed.  
2) This model can help explore the changes in the circuitry caused by different perturbation of 
system including repeated administrations of Meth (Meth addiction studies) and changes in the 
state of the system by administration of other pharmacological agents. Due to the complexity of 
the system, differences in responses may prevent us from unequivocal discoveries about 
underlying mechanisms. Instead, we can use some statistical inference applied to the changes of 
model parameters. For instance, after injection of an antagonist for some receptors, using this 
model we can expect a noticeable reduction in interconnectivity of some components of the 
neural network. In this case, we can conclude that the impacted neurotransmitter mediates this 
connection. Finally, in repeated drug consumption, the perturbations of related model parameters 
can help us understand the drug tolerance and addiction better. 
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 OREXINERGIC NEUROTRANSMISSION IN CHAPTER 2.
TEMPERATURE RESPONSES TO METHAMPHETAMINE AND 
STRESS                                                                                                  
2.1 Introduction 
Amphetamine and its derivatives are among the most prevalent abused drugs in the world [22]. 
Amphetamines can cause various medical complications including myocardial infarctions, 
ischemic and hemorrhagic strokes, rhabdomyolysis, renal failure, and fatal hyperthermia [23-29]. 
Despite this, there is little understanding of neural mechanisms underlying hyperthermia 
produced by amphetamines. For instance a similar dose of amphetamine may cause a mild effect 
in some patients but be fatal to others; this can occur even though the blood levels of the drug 
appear low [30, 31]. 
In rats, amphetamines cause the central release of monoamines and the subsequent activation of 
the sympathetic nervous system causing in heat generation by brown adipose tissue (BAT) [32, 
33] and skeletal muscle [34]. In addition, amphetamines decrease heat dissipation through 
cutaneous vasoconstriction [35, 36]. The brain areas mediating these effects are not known but it 
has previously shown that sympathetic and behavioral responses mediated, by the substituted 
amphetamine MDMA, can be prevented by suppressing neuronal activity in the dorsomedial 
hypothalamus [10], the area which is now well-established to participate in the control of heat 
production in the BAT and heat dissipation through the skin [8]. This is one of the few brain 
regions containing neurons that project trans-synaptically to both the adrenal gland and skeletal 
muscle [37] and these dual-projecting neurons contain the peptide orexin [38]. It has also been 
further shown that Meth and d-amphetamine activate orexin-containing neurons [39, 40]. 
Central activation of orexin receptors increases body temperature, BAT sympathetic nerve 
activity and thermogenesis, plasma epinephrine, and heart rate [41-45]. The systemic 
administration of SB-334867 (SB), an OX1R antagonist, hereinafter referred as SB, prevents 
increases in heart rate and mean arterial pressure in models of stress and panic [46, 47], and 
suppresses hyperthermia caused by stress of injection [48]. Pretreatment with SB has also been 
shown to significantly attenuate hyperthermia evoked by a moderate but not a low or high dose 
of Meth [48]. Unfortunately, in the cited study temperature fluctuations resulting from the stress 
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of two intraperitoneal injections (SB and Meth) made it impossible to quantify the effect of SB 
on low doses of Meth using a traditional data analysis.  
The differential effects of SB on the temperature responses to different doses of Meth do not 
allow for a straight-forward interpretation. Recently, Molkov et al. developed a mathematical 
model [1] that reproduced dose-dependent temperature responses to methamphetamine. The 
model described interactions of putative brain nuclei that participate in thermoregulation. We use 
this model to provide mechanistic explanation of how the orexin antagonist SB-334867 affects 
complex Meth-induced dynamics of the body temperature. 
2.2 Methods and Data preparations 
To study the effect of SB-334867 on methamphetamine-evoked temperature responses two 
separate experimental series were performed. In the first series SB was administered in the dose 
of 10 mg/kg. In second series, SB was administered in the dose 30 mg/kg. In each study we have 
used the corresponding vehicles. 
In each series rats were randomly assigned to one of eight groups (n=6-8 per group): one of two 
pretreatments (SB vs vehicle), followed by one of four treatments (saline or one of three doses of 
Meth). Each rat received only one treatment. Experiments were performed in a temperature 
controlled room at T=25
o
C and relative humidity 30-70%. Air temperature and humidity were 
monitored by independent sensors. For all experiments deviations of the temperature from 25ºC 
did not exceed 0.8ºC. After baseline physiological parameters were recorded for at least 30 min, 
animals received an intraperitoneal injection of either vehicle or SB-334867. Thirty min later, 
rats received an intraperitoneal injection of either saline or one of three doses of 
methamphetamine (1 mg/kg, 5 mg/kg, or 10 mg/kg). Although there is a wide range of 
methamphetamine doses that humans abuse, the doses we chose include ones that are commonly 
used recreationally (1 mg/kg) as well as larger doses that may be reached by binge users (5 and 
10 mg/kg) [49]. For convenience we refer to these doses as “low”, “moderate”, and “high” 
respectively. Each rat was used for only one injection of Meth or saline. 
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2.3 Model Construction 
2.3.1 General Approach 
In their studies [1] Molkov et al. were able to fit experimental data on dose-dependence of 
temperature responses to Meth with appropriate precision using a mathematical model which 
was constructed using known anatomy of circuitry involved into responses to amphetamines. 
The core of the model is a feed-forward sequence of connected excitatory nodes: Excitatory (Exc, 
putatively hypothalamic), Medullary (Med) and sympathetic premotor node (SPN), out of which 
SPN directly defines a heat generation output (Figure ‎2.1). We assume that the signal from SPN 
is transmitted “as is” to the effector organs controlling thermogenesis. This allows combining the 
whole downstream chain into a single output. Excitatory node is sensitive to Meth as well as 
there are two more Meth-sensitive nodes – Inhibitory (Inhib) and “high dose” (HD). The 
Inhibitory drive competes with the Excitatory input to affect the Medullary node, while the HD 
node requires high dose of Meth to be activated, hence the name. Complex dose-dependence of 
temperature responses to Meth is formed by the competition of two excitatory inputs and one 
inhibitory input, all of which have different sensitivities to Meth.  
 
Figure ‎2.1 Schematic of the model neuronal circuitry involved in responses to 
methamphetamine. Stress input and the orexin receptors (shown by gray rectangles 
labeled “OX”) are added to extend the circuitry used in [1]. Effect of Stress and/or Meth 
can be affected by the orexin receptor antagonist SB-334867. Each circle represents a 
neural population. Abbreviations:  Exc – excitatory node, Inhib – inhibitory node, HD – 
high-dose activated node, Med – medullary node, SPN – sympathetic preganglionic node, 
TEMP – temperature. 
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Low doses of Meth (1 mg/kg i.p. and below) activate the Excitatory node almost exclusively, and 
administration of those doses evokes a monophasic mild hyperthermia.  Higher doses (3-5 mg/kg 
i.p.) are able to activate the inhibitory node, which completely masks the activity of the 
Excitatory node. As a result, immediately after injection of Meth there is no temperature 
response, but after partial elimination of the drug, the excitatory drive is disinhibited, and 
temperature increases display a delayed monophasic response. Finally, high doses (10 mg/kg i.p.) 
activate the HD node, and cause immediate powerful hyperthermia followed by a secondary 
temperature increase due to transient activation of the Excitatory node. 
To analyze the orexin data we first modified the existing model to accommodate stress. Since 
inhibition of the dorsomedial hypothalamus, a putative excitatory node, suppresses sympathetic 
activation from both stress [50] and amphetamines [10], we hypothesized that stress and Meth 
both provide direct inputs to the Excitatory node. Each stress stimulus was modeled as a spike of 
activity of short duration.  
Next, we assumed that SB affects Meth and stress inputs at the relevant nodes. Excitatory node 
exhibits some tonic activity without Meth [1]. If the projections from Excitatory and/or 
Inhibitory node to Medullary node are orexinergic, the antagonist would cause dramatic (up to 
3
o
C) hypothermia by itself. However, as it will be shown in the Results, the administration of the 
antagonist alone did not result in any hypothermia whatsoever. Therefore, we were restricted to 
placing orexin receptors on the Meth-sensitive populations to mediate effects of Meth, but not to 
cause any perturbations by the receptor blockade alone.  
By fitting the temperature responses to Meth after different doses of SB we calculated values of 
the model parameters. 
2.3.2 Implementation of the Model 
The model consisted of three components: pharmacokinetics describing concentration of Meth in 
the blood after injection; a neural network whose activity was dependent on Meth and SB; and a 
temperature control system driven by a signal from the neural network. 
We assumed that after the injection the drug is being absorbed in the blood from the peritoneum 
and is also being eliminated from the blood.  Accordingly, drug concentrations are described by 
the following equations: 
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𝑑[𝑀𝑝]
𝑑𝑡
= −
[𝑀𝑝]
𝜏𝑢
 
   
𝑑[𝑀]
𝑑𝑡
=
[𝑀𝑝]
𝜏𝑢
−
[𝑀]
𝜏𝑑
 
(‎2.1) 
 
where t is time in minutes, 𝑀𝑝 is the intra-peritoneal drug concentration, and 𝑀 is the blood drug 
concentration (both in mg/kg). [𝑀𝑝] 𝜏𝑢⁄  represents drug absorption with time constant 𝜏𝑢, and 
[𝑀] 𝜏𝑑⁄  represents drug elimination with time constant 𝜏𝑑. Initial conditions are [𝑀𝑝](0) = 𝐷, 
[𝑀](0) = 0 for injections made at time 0 where D is the initial dose of the drug being modeled. 
System (‎2.1) can be solved explicitly as: 
 
 [𝑀](𝑡) = 𝐷 (
𝜏𝑢
𝜏𝑑
 − 1)
−1
(𝑒−𝑡 𝜏𝑢⁄ − 𝑒−𝑡 𝜏𝑑⁄ ) (‎2.2) 
 
for 𝑡 > 0, and [𝑀](𝑡) = 0 if 𝑡 < 0. Stress input from the injection made at 𝑡 = 𝑡0 was modeled 
as a single exponential function 
 𝑆(𝑡, 𝑡0) = {
𝑒−(𝑡−𝑡0) 𝜏𝑠⁄ , if 𝑡 > 𝑡0
0, if 𝑡 ≤ 𝑡0
 (‎2.3) 
 
 
In their study, the neural circuitry is modeled as a feed-forward artificial neural network.  The 
excitatory node Exc receives two stress inputs at 𝑡 = −30 min and 𝑡 = 0 min from injections of 
SB (or vehicle) and Meth (or saline) respectively. The outputs of Meth-sensitive neural 
populations are calculated as follows: 
 
 
𝑃𝐸𝑥𝑐(𝑡) = 𝜎(𝑤𝑆𝑆(𝑡, −30) + 𝑤𝑆𝑆(𝑡, 0) + 𝑤𝐸𝑥𝑐[𝑀](𝑡) + 𝛾𝐸𝑥𝑐) 
𝑃𝐼𝑛ℎ(𝑡) = 𝜎(𝑤𝐼𝑛ℎ[𝑀](𝑡) + 𝛾𝐼𝑛ℎ) 
𝑃𝐻𝐷(𝑡) = 𝜎(𝑤𝐻𝐷[𝑀](𝑡) + 𝛾𝐻𝐷) 
 
(‎2.4) 
where 𝜎(𝑥) = (1 + tanh𝑥) 2⁄   is a sigmoid activation function, 𝑤𝑖(𝑡) is the sensitivity of 𝑃𝑖(𝑡) 
to Meth, and 𝛾𝑖 is the basal excitability of 𝑃𝑖, 𝑖 ∈ (𝐸𝑥𝑐, 𝐼𝑛ℎ, 𝐻𝐷). To account for the effect of the 
SB, we used different values of (𝑤𝑆, 𝑤𝐸𝑥𝑐 , 𝑤𝐼𝑛ℎ, 𝑤𝐻𝐷) for different doses of SB. 
The activity of medullary population Med is described as follows: 
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 𝑃𝑀𝑒𝑑(𝑡) = 𝑤𝐸𝑥𝑐→𝑀𝑒𝑑𝑃𝐸𝑥𝑐(𝑡) − 𝑤𝐼𝑛ℎ→𝑀𝑒𝑑𝑃𝐼𝑛ℎ(𝑡) (‎2.5) 
where 𝑤𝐸𝑥𝑐→𝑀𝑒𝑑 and 𝑤𝐼𝑛ℎ→𝑀𝑒𝑑 are the weights of the excitatory and inhibitory projections from 
Exc to Med and Inhib to Med, respectively. Inframedullary population SPN transmits the activity 
of Med but is additionally excited by the Meth-sensitive HD population as follows: 
 𝑃𝑆𝑃𝑁(𝑡) = 𝑃𝑀𝑒𝑑(𝑡) + 𝑤𝐻𝐷→𝑆𝑃𝑁𝑃𝐻𝐷(𝑡) + 𝛾𝑆𝑃𝑁 (‎2.6) 
where 𝑤𝐻𝐷→𝑆𝑃𝑁 is the weight of the excitatory projection from HD to SPN, and 𝛾𝑆𝑃𝑁 is the basal 
excitability of SPN. 
The temperature response is modeled by a first-order linear ODE driven by the SPN signal as 
follows: 
 𝜏𝑇
𝑑𝑇
𝑑𝑡
= 𝑃𝑆𝑃𝑁(𝑡) − (𝑇 − 𝑇0) (‎2.7) 
where T is the body temperature in degrees Celsius, 𝜏𝑇 is the time constant of the temperature 
response, and 𝑇0 is the baseline body temperature. 
2.3.3 Estimation of the Model’s parameters 
We used the Bayesian approach for inferring the model parameters. Then, statistical analysis is 
used to estimate statistical significance of changes in (𝑤𝑆 , 𝑤𝐸𝑥𝑐 , 𝑤𝐼𝑛ℎ, 𝑤𝐻𝐷) individually when 
30, 10, and 0 mg/kg of SB are injected, respectively. To do this, we constructed a corresponding 
posterior probability density function (PDF) of the parameter vector = (𝑤𝑆 , 𝑤𝐸𝑥𝑐 , 𝑤𝐼𝑛ℎ, 𝑤𝐻𝐷) 
considering other parameters fixed at values shown in the Table ‎2.1. According to Bayes' rule, 
this probability distribution is proportional to the probability that an observed temperature time 
series {𝑇𝑖} is produced by their model with the given 𝑾, usually referred to as a likelihood. 
Assuming that the residuals are normally distributed, the posterior PDF 𝑝(𝑾 ∣ {𝑇𝑖}) is given by 
the following formula: 
 𝑝( 𝑾 ∣ {𝑇𝑖} ) = exp {− ∑   
[𝑇𝑖 − 𝑇(𝑾, 𝑖)]
2
2𝜎𝑖
2
180
i=−50
} (‎2.8) 
 
where 𝑇(𝑾, 𝑖) is the temperature calculated by their model at time i with the given W. 𝑇𝑖 and 𝜎𝑖 
are respectively a mean and a standard deviation of the body temperature over a corresponding 
group of animals at time i by increments of 2 minutes. 
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We used the Markov Chain Monte Carlo (MCMC) approach, in particular the modified 
Metropolis-Hastings algorithm [51-54], to create an ensemble of points distributed according to 
the PDF (‎2.8). Once we had the ensembles, we calculated mean values of the parameters and 
their standard errors for each group: vehicle, SB10, and SB30, and used two-sample z-test to 
estimate statistical significance of the differences in parameter values between the groups. We 
assumed that p-value < 0.05 means that SB has a statistically-significant effect on the 
corresponding parameter of the model. 
Table ‎2.1 Values of parameters that were considered not affected by SB (adapted from [1]) 
2.4 Results 
2.4.1 SB suppresses stress-induced hyperthermia 
The first intraperitoneal injections evoked increases in the body temperature, which tended to 
return to baseline before the second injection in some groups. We have pooled the responses to 
the first injection in all groups before administration of Meth according to pretreatment to make 
four groups (two doses of SB and two vehicles for each dose of SB). However, there was no 
difference between responses to different vehicles, so data for both vehicles were pooled together 
as a single group. This reduced the number of groups to three. The increase of body temperature 
in response to the first injection was statistically significantly attenuated by both doses of SB 
(Figure ‎2.2), whereas there was no statistically significant difference between the two doses of 
SB (p>0.05). 
Parameter Value Parameter Value 
𝝉𝒖(𝑴𝒆𝒕𝒉), min 8.25 𝜏𝑇, min 89.2 
𝝉𝒅(𝑴𝒆𝒕𝒉), min 57.5 𝑇0, °𝐶 37 
𝝉(𝑺𝒕𝒓𝒆𝒔𝒔), min 10 γ
Exc
 , 𝑚𝑔/𝑘𝑔 −0.357 
𝒘𝑬𝒙𝒄→𝑴𝒅𝒍 , °𝑪 9.89 γInh , 𝑚𝑔/𝑘𝑔 −1.335 
𝒘𝑰𝒏𝒉→𝑴𝒅𝒍 , °𝑪 6.38 γHD , 𝑚𝑔/𝑘𝑔 −3.69 
𝒘𝑯𝑫→𝑺𝑷𝑵 , °𝑪 5.66 γSPN , °𝐶 −3.35 
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Figure ‎2.2 Effect of SB on stress-induced body temperature increase associated with 
injections (n=24-26 per group).  Black circles, solid line – pooled vehicle data; open 
circles, solid line – SB 10 mg/kg; open circles, dashed line – SB 30 mg/kg. Injection was 
performed at t = –30 min. 
 
2.4.2 Effects of SB-334867 on temperature responses to Meth 
The effects of Meth on body temperature were not different between the two vehicles used for 
the different doses of SB. These effects had complex dose-dependence, which has previously 
been described [1, 17, 48, 55].  In short, low (1 mg/kg) and high doses of Meth (10 mg/kg) 
evoked virtually immediate response while response to intermediate dose (5 mg/kg) was delayed. 
Peak hyperthermia after low and intermediate doses was similar (38.2 ± 0.1 oC vs 38.2±0.1  oC) 
but occurred at different moments (76+11 min vs 226+15 min after injection). The highest dose 
of Meth evoked a robust hyperthermia with temperatures reaching 39.5±0.2 °C within 90 min of 
administration with the temperature subsequently declining from 90 to 150 min, followed by a 
plateau until the end of the recording period (up to 200 min). Injections of saline evoked slight 
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increases of body temperature, which were short-lived: temperature returned to baseline within 
60 min. 
The responses to the same doses of Meth after SB are shown in Figure ‎2.3, after the low dose of 
Meth (1 mg/kg), rats treated with SB had lower body temperature than rats treated with vehicle 
during 3 h after administration of Meth (Figure ‎2.3 B, F). However, this difference did not at any 
time reach statistical significance in the experiment with the lower dose of SB (10 mg/kg, 
Figure ‎2.3 B). However, the suppression of the response to the low dose of Meth became 
statistically significant after the injection of higher dose of the antagonist (30 mg/kg, Figure ‎2.3 
F).  
Next, after an intermediate dose of Meth (5 mg/kg) temperature transiently increased but 
remained lower than temperatures in the vehicle group. Furthermore, this dose of SB 
significantly attenuated thermogenic response after 70-90 min. In contrast, after the higher dose 
of SB (30 mg/kg) intermediate dose of Meth evoked a rapid hyperthermic response (Figure ‎2.3 
G) such that core temperature rose statistically significantly above the vehicle group. 
Qualitatively this response resembles a temperature response to a high dose of Meth in the 
vehicle group (Figure ‎2.3 D). 
Finally, the response to a high dose of Meth (10 mg/kg) was not modified by the lower dose of 
SB (Figure ‎2.3 D) whereas the higher dose of SB significantly increased and prolonged the 
response to the high dose of Meth with the difference progressively increasing for over 120 min 
after the administration of Meth. 
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Figure ‎2.3 Changes in the body temperature evoked by Meth after two doses of SB-334867, 
Meth is injected at t = 0 min (dashed lines). SB is injected 30 min prior to Meth. A-D: SB 
10 mg/kg; E-H: SB 30 mg/kg. Each plot contains responses to the dose of Meth shown on 
the left: 0 (Saline), 1, 5 or 10 mg/kg after injection of either vehicle (black circles) or SB 
(open circles). 
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2.5 Effects of SB on estimates of the model parameters 
In this study we used the Metropolis algorithm to implement a Markov Chain Monte Carlo 
approach to estimate the posterior distribution of model parameters. Specifically, this algorithm 
generates a multidimensional cloud of points in the parameter space distributed according to the 
PDF (formula 8 in Methods) for a given experimental series {𝑇𝑖}. Four parameters (𝑤𝑆 , 𝑤𝐸𝑥𝑐 ,
𝑤𝐼𝑛ℎ, 𝑤𝐻𝐷)  have been sampled for three different doses of SB. We demonstrate the 
corresponding clouds in projections onto (𝑤𝐸𝑥𝑐 , 𝑤𝐼𝑛ℎ)  and onto (𝑤𝑆, 𝑤𝐻𝐷)-planes shown in 
Figure ‎2.4 A and Figure ‎2.4 B respectively. Each panel contains three clouds labeled “Vehicle”, 
“SB, 10 mg/kg” and “SB, 30 mg/kg”. These clouds are well separated implying that the 
differences in parameter values are statistically significant. 
Statistical analysis confirms that antagonism of orexin receptors leads to statistically significant 
changes in estimates of the model parameters. Particularly, the stress amplitude 𝑤𝑆 is reduced by 
administration of the orexin antagonist (Figure ‎2.4 C), although, there was no significant 
difference in 𝑤𝑆  estimates between 10 and 30 mg/kg of the antagonist. Also, parameters of 
sensitivity to Meth of both excitatory and inhibitory drives, 𝑤𝐸𝑥𝑐 , 𝑤𝐼𝑛ℎ , were decreased by 
administration of SB (Figure ‎2.4 D,E). The suppression was dose-dependent. The lower dose of 
the antagonist significantly decreased  𝑤𝐸𝑥𝑐  , but the effect was virtually absent for 𝑤𝐼𝑛ℎ . 
However, the higher dose of SB was much more efficient in suppressing the Meth sensitivity of 
both the inhibitory and excitatory drives. Finally, the Meth sensitivity of HD node was 
progressively increased with increasing dose of SB (Figure ‎2.4 F) implying an ability of this 
population to be activated by progressively lower doses of Meth. 
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Figure ‎2.4 Parameter estimates generated by Monte-Carlo simulations, A-B: Statistical 
ensembles of parameters (amplitude of stress, and Meth-sensitivities of three Meth-
dependent populations) projected onto (𝑤𝑆, 𝑤𝐻𝐷)-plane (A) and (𝑤𝐸𝑥𝑐 , 𝑤𝐼𝑛ℎ)-plane (B) for 
each of the three doses of SB (vehicle, 10 and 30 mg/kg). C-F: Individual parameters for 
each dose of SB. * denotes statistically significant difference from vehicle (SB 0, p<0.05) 
between SB 10 and SB 30 (p<0.05). 
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2.6 Effects of SB on the network components 
Of particular interest is how SB-evoked changes in the parameters of the model affect activation 
profiles of Meth-sensitive network components. Activities of Exc, Inhib and HD as functions of 
the blood concentration of Meth are shown at Figure ‎2.5 A, B and C. SB downgrades the slope 
of the dose-dependence curve in case of Exc and Inhib, which signifies desensitization of these 
nodes (more Meth is required to evoke same response). The effect of SB on Exc is significant for 
both doses of antagonist and increases with dose. In contrast, an effect of the lower dose of SB 
on Inhib is subtle. Unlike two other Meth sensitive populations, HD gains higher sensitivity to 
Meth when SB is present as its dose-dependence curve shifts to the left. Therefore, lower 
concentrations of Meth are able to activate this neuronal population.  
Superposition of inputs from these populations results in complex modification of SPN activity 
which ultimately controls the thermal response. The dose-dependence of SPN activity is shown 
in the Figure ‎2.5 D, which is aligned with simulated pharmacokinetic profile of Meth after 
various doses of Meth used in this study (Figure ‎2.5 E). The low dose of Meth (1 mg/kg, Meth-1 
in Figure ‎2.5 E) does not evoke any significant response when either of SB doses is present.  
The intermediate Meth dose (5 mg/kg, Meth-5 in Figure ‎2.5 E) is sufficient to elicit strong 
thermogenesis after the higher dose of SB (30 mg/kg, SB30 in Figure ‎2.5 D) but not after the 
lower dose of the antagonist (10 mg/kg, SB10 in Figure ‎2.5 D). 10 mg/kg of SB desensitizes Exc, 
barely affects Inhib, and sensitizes HD. Together these changes leave the activity of SPN at the 
peak Meth concentration caused by the injection of 5 mg/kg of Meth almost unaltered 
(Figure ‎2.5 D, E). In contrast, 30 mg/kg of SB sensitize HD a little more (Figure ‎2.5 C), but more 
importantly this dose substantially desensitizes the Inhib population (Fig. 5B) leading to 
disinhibition of SPN activity (compare SB10 and SB30 in Figure ‎2.5 D). 
As mentioned SB induces sensitization of HD population to Meth (Figure ‎2.4 F, Figure ‎2.5 C) 
which results in longer activation of the HD component by the same Meth concentration profile 
(Meth-10 in Figure ‎2.5 E) due to progressively lower HD activation threshold (compare Veh, 
SB10 and SB30 in Figure ‎2.5 D). 
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Figure ‎2.5 Activation curves of nodes of the model compared with pharmacokinetics of 
Meth. A-D: Activity of the network nodes as functions of Meth concentration in the blood 
after three doses of SB-334867: 0 (Veh), 10 and 30 mg/kg using best fit parameters. E: 
Time courses of the Meth concentration after different doses of Meth (1, 5 and 10 mg/kg) 
as generated by the model. 
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2.7 Effects of SB on the temperature responses to Meth 
2.7.1 Control responses to Meth 
Without SB and Meth, injections of the vehicle and saline cause stress which activates Exc (see 
Fig. 1). This activation results in two early “peaks” of temperature in the beginning due to two 
injections separated by 30 min, followed by a decline to baseline (Fig. 6A).  
For 1 mg/kg of Meth, stress and Meth together activate Exc far greater than Inhib resulting in 
higher and longer maximum temperature after 1 mg/kg than after saline, however, the gradual 
decline afterwards was similar (Fig. 6B).  
Following the vehicle, the intermediate dose of Meth (5 mg/kg) activates both Exc and Inhib to 
their full extent effectively cancelling each other, and the second “stress bump” almost 
completely disappears. Accordingly, the body temperature does not react until after 60 min when 
the Meth concentration falls below the activation threshold of Inhib. This explains the plateau 
and gradual increase in temperature in the late phase (Fig. 6C).  
Finally, after 10 mg/kg of Meth at the early stage the activation levels of Exc and Inhib are 
saturated and negating each other. HD component is activated which results in an immediate 
robust temperature increase (Fig. 6D). After approximately 70 min the Meth concentration falls 
below HD’s activation threshold, and the temperature starts declining. Later on, in about 120 min, 
Meth decreases enough to deactivate Inhib and, thus, to disinhibit Exc which temporarily slows 
the temperature drop or even initiates a secondary peak (not seen in Fig 6D). 
For more details about temperature responses to Meth alone see [1]. 
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Figure ‎2.6 Comparison of experimental data and model responses, Experimental data 
shown by open circles (average temperature); error bars represent standard deviations 
over a group of rats. Model responses using best fit parameters are shown as thick lines. 
SB vehicles for both doses were pooled into a single group. Columns of graphs 
correspond to different doses of the antagonist (A-D: Vehicle, E-H: 10 mg/kg and I-K: 30 
mg/kg as marked at the top), rows of graphs correspond to different doses of Meth 
(Saline, 1, 5 and 10 mg/kg, as marked at the left). 
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2.7.2 Responses to Meth after SB 
Administration of SB itself results in a spike in temperature due to stress caused by the injection 
which is partially suppressed by the drug (Figure ‎2.2). The second bump on the temperature 
curve in Fig. 6E corresponds to the injection of saline. The suppression of the responses to stress 
does not increase significantly with increasing dose of the orexin antagonist (compare Figure ‎2.6 
E and I).  
After administration of SB the temperature response to the low dose of Meth does not exceed 
that of animals injected with saline (compare Figure ‎2.6 F, J and E, I) suggesting that the 
temperature responses to the low dose of Meth are eliminated (see Figure ‎2.5 D). 
At the intermediate dose of Meth (5 mg/kg) the temperature responses are noticeably and 
differentially altered by 10 and 30 mg/kg of SB (Figure ‎2.6 C, G, K). After 10 mg/kg of SB the 
temperature curve loses the late ascending phase present in Figure ‎2.5 C. This modification is 
concerned with SB-evoked desensitization of Exc to Meth (see Figure ‎2.4 D, Figure ‎2.5 A, D). 
After the higher dose of SB (30 mg/kg) there appears strong immediate hyperthermia (Figure ‎2.6 
K) explained by sensitization of HD and desensitization of Inhib (Figure ‎2.5 B, C, D). 
Finally, after 10 mg/kg of Meth, both Exc and Inhib are activated to some extent by overcoming 
the blockade, but activation of HD overshadows the activity of the two, producing progressively 
larger temperature increase with increasing dose of SB (Figure ‎2.6 D, H, L). This augmented 
hyperthermia as well as its longer duration is also mediated by SB-induced sensitization of the 
HD node and desensitization of Inhib to Meth (see Figure ‎2.5). 
2.7.3 Mechanism of HD sensitization 
Orexin is an excitatory neurotransmitter [56]. Accordingly, a blockade of orexin receptors is 
expected to reduce the activity of the postsynaptic neurons in presence of orexinergic synaptic 
inputs. From this perspective, the desensitization of Exc and Inhib populations by the orexin 
antagonist allows for a straightforward interpretation. Specifically, we can assume that these two 
nodes receive orexinergic projections from Meth-activated neurons, and, hence, these inputs are 
suppressed by the orexin receptor antagonism (see Figure ‎2.2).  
In the model presented in Figure ‎2.1 we assumed that SB affects the parameters of sensitivity of 
Meth-dependent populations 𝑤𝐸𝑥𝑐 , 𝑤𝐼𝑛ℎ. This worked out very well to reproduce the data and is 
consistent with orexin excitatory action. In contrast, the HD population gets sensitized by the 
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antagonist, which contradicts to the excitatory influence of orexin. Therefore, we assume that 
Meth-activated excitatory input, which this node receives, is not mediated by orexin. Instead, HD 
node may receive strong inhibition from another neural population whose activity is controlled 
by orexin receptors. In the presence of the orexin antagonist the activity of this inhibitory 
population gets reduced which in turn disinhibits HD (Figure ‎2.7 A).Therefore, progressive 
sensitization of HD (Figure ‎2.4 F), which was described above by an increase in 𝑤𝐻𝐷, is more 
likely a result of HD disinhibition as illustrated in Figure ‎2.7 A. 
The orexinergic drive in Figure ‎2.7 A can be Meth-dependent or Meth-independent. In the 
former case the net Meth-dependent input to HD will be defined by the difference of Meth-
induced excitation and inhibition. In presence of SB, the inhibition is reduced which results in 
the increased HD sensitivity to Meth characterized by the parameter 𝑤𝐻𝐷. In the latter case, the 
orexin antagonist does not affect the Meth-dependent input directly. It rather alters the basal 
excitability of the HD population defined by the orexin-dependent tonic inhibition it receives. 
Accordingly, a more biologically correct way to describe this is to alter 𝛾𝐻𝐷 for different doses of 
SB, rather than 𝑤𝐻𝐷. 
𝛾𝐻𝐷 estimates obtained by Monte Carlo simulations using (𝑤𝑆 , 𝑤𝐸𝑥𝑐 , 𝑤𝐼𝑛ℎ, 𝛾𝐻𝐷) as a set of SB-
affected parameters are shown in Figure ‎2.7 B. As expected, this parameter progressively 
declines with increasing SB dose which leads to changes in HD activation curve almost 
indistinguishable from shown in Figure ‎2.5 C. Obviously, the likelihood for these two models is 
almost the same, and hence they are equally probable from Bayesian standpoint.  
To summarize, the sensitization of HD component of the network is concerned with its 
disinhibition. Their experimental data does not allow for a conclusion if this inhibition is Meth-
activated or not. 
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Figure ‎2.7 Interpretation of HD sensitization as a change of inhibitory tone to the HD: A: 
The mechanism of HD sensitization by the orexin receptor antagonist. SB suppresses 
activation of the inhibitory population InhHD by orexinergic input which disinhibits HD 
and thus lowers its activation threshold. B: Effect of SB on the basal inhibitory tone to 
HD population 𝛾𝐻𝐷 when it is used as an SB-affected parameter instead of 𝑤𝐻𝐷. * - the 
estimate is statistically significantly different from the one for Vehicle (SB-0, p<0.05); # 
- the estimates are statistically significantly different between SB 10 and SB 30 (p<0.05). 
See Results for more details. 
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2.7.4 Effect of inhibition failure 
The inhibitory control of HD population described above may originate from the Inhib node of 
the circuitry (see Figure ‎2.1). In this case we can synthesize the network architecture by 
combining the schematics from Figure ‎2.1 A and Figure ‎2.7 A as shown in Figure ‎2.8 A. We 
implemented a corresponding mathematical model and found that it fitted our experimental data 
with comparable precision (not shown) and hence had similar likelihood.  
This model has a very important implication for the role of inhibition in this system. Indeed, both 
excitatory components, Exc and HD, appear to be controlled by the inhibitory drive whose 
failure may have dramatic consequences. Our simulations demonstrate the consequences of such 
failure. Figure ‎2.8 B demonstrates how temperature responses to Meth change if the maximal 
activity of Inhib population is bounded. In our simulations we used a relatively low dose (3 
mg/kg) which does not produce major response under baseline conditions (see unmodified 100% 
inhibition in Figure ‎2.8 B). If the maximal activity of the Inhib population was decreased by two 
times (50% inhibition), the body temperature rose by almost 2 degrees. When Inhib was 
completely silenced, the body temperature reached life-threatening levels at almost 40
o
 C (0% 
inhibition in Figure ‎2.8 B). 
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Figure ‎2.8 Reduced model and effect of inhibitory failure on the response: A. The extended 
model schematic in which the inhibitory tone to HD originates from Inhib population (see 
explanations in the Results). B: Effect of inhibitory failure in the modified model on the 
response to 3 mg/kg of Meth (see details in the Results). 
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2.8 Discussion 
2.8.1 Biological Implication 
This study builds upon previously published mathematical models [1], which were based on the 
premise that body temperature response to Meth is dependent upon the interaction between two 
neural components: excitatory and inhibitory drives. The difference in strength between these 
two signals ultimately determines the dynamics of body temperature. 
The injections of SB (0 mg/kg, 10 mg/kg, and 30 mg/kg) differentially modify temperature 
responses to low, intermediate and high doses of Meth (0 mg/kg, 1 mg/kg, 5 mg/kg, and 10 
mg/kg). Previously it was reported that 10 mg/kg of SB suppressed the temperature response to 
stress of injection and also late hyperthermia induced by the intermediate (5 mg/kg) dose of 
Meth [48]. The limited conclusiveness of that study was concerned with the fact that SB-related 
effects on the temperature response in the early phase (t < 60 min) were impossible to separate 
from stress-induced temperature fluctuations resulting from two intraperitoneal injections. 
In this study using mathematical modeling we were able to reliably decompose the effect of SB 
into stress- and Meth-related components, and thus provide a straight-forward mechanistic 
explanation for the intricate alterations of the temperature responses to different doses of Meth 
induced by orexin receptor antagonism. 
2.8.2 Two excitatory components in temperature responses to Meth 
In publication [1], where the authors suggested the circuitry shown in Figure ‎2.1 to explain the 
complexity of the temperature responses to Meth, they also considered an alternative model 
where the excitatory populations, Exc and HD, were combined into a single excitatory node. The 
data used in that study failed to emphasize the plausibility of either architecture. 
In the present study we have shown that two distinct excitatory populations are necessary to 
explain differential effects of the orexin receptor antagonist on the responses to low and high 
doses of Meth. Specifically, activation of the first excitatory population (Exc in Figure ‎2.8 A) by 
low doses of Meth is mediated by orexinergic neurotransmission, while the direct Meth-
dependent input to the second population (HD) does not rely on orexin receptor activation. 
The details of the network architecture shown in Figure ‎2.7 A and Figure ‎2.8 A clarify the nature 
of high activation threshold of the HD component which is yet another distinctive feature of the 
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second excitatory population in the network. The lack of response of this population to low doses 
of Meth is not concerned with its lower sensitivity, but rather defined by a tight inhibitory 
control originated either from Inhib or some other inhibitory neuronal population(s). High doses 
of Meth are needed to overcome this inhibition. In either case the source of this inhibition is 
dependent upon orexinergic input. Orexin receptor antagonism suppresses the inhibition and thus 
lowers HD activation threshold which underlies SB-induced exaggeration of responses to high 
doses of Meth. 
2.8.3 Biological implications 
The results of this work have several important implications to consider. 
Amphetamines are known to activate orexin-containing neurons in the perifornical area [39, 40]. 
From the phenomena observed in our experiments we conclude that this activation of orexinergic 
cells is required for temperature responses to Meth.  The entire hypothalamus including 
dorsomedial hypothalamus contains orexin-containing fibers [57], which can mediate the above 
effects of Meth. However, this activation can be mono- or polysynaptic (for example, 
perifornical area – ventral tegmental area – hypothalamus, or have even more connections). 
The Inhib population in the network plays an extremely important role in counteracting 
hyperthermia. Previously, Molkov et al. have demonstrated that an imbalance of excitatory and 
inhibitory components can result in significant amplification of the response to relatively low 
doses of Meth [1]. The details of the circuitry proposed in this study emphasize the importance 
of the inhibitory component(s) even more. Simulations shown in Figure ‎2.8 B demonstrate that a 
relatively low dose (3 mg/kg), which does not induce virtually any response in intact animals 
(see 100% inhibition in Figure ‎2.8 B), can evoke profound hyperthermia typical for much higher 
doses (compare 0% inhibition in Figure ‎2.8 B with Figure ‎2.6 D). The impairment of the 
inhibitory control can not only allow excitation to pass through Med, but also lower the HD 
activation threshold so that this population gets activated by relatively low Meth doses. 
Another implication of our results is that using orexin receptor blockade as a treatment for other 
ailments could cause life-threatening side effects. In particular, orexin antagonists were proposed 
to prevent or treat addictions to various drugs [58, 59]. An increase in excitability of the HD 
population in presence of SB highlights a potential danger of its use to treat drug abuse if the 
person uses the drug during treatment. Indeed, suppression of acute effects of amphetamines by 
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the orexin antagonist may force an abuser to increase the dose which may cause life-threatening 
hyperthermia due to a dysfunction of the inhibitory population(s).  Similarly, our model predicts 
that narcoleptic patients, whose condition is putatively caused by a lack of orexin [60], may be at 
higher risk of life-threatening overdose of amphetamine-like stimulants, which are usually 
prescribed to treat such patients [61]. 
[45] reported that administration of orexin into raphe pallidus evoked activation of 
thermogenesis in the BAT and increased body temperature in anesthetized rats. Surprisingly, 
local microinjection of SB into the same area also induced thermogenesis and hyperthermia [45]. 
Our analysis provides possible interpretation of this data as the network has both excitatory and 
inhibitory populations activated by orexin. Namely, activation of the excitatory drive by orexin 
can evoke thermogenic response, whereas a blockade of orexin receptors in the inhibitory 
population will remove the inhibitory tone which may result in a similar effect.  
2.9 Conclusions 
In this study, using mathematical modeling, we mechanistically explained non-trivial alterations 
of temperature response to various doses of Meth at presence of the orexin receptor antagonist. 
Our model can be used to generate experimentally-testable predictions on the thermogenic 
effects of Meth when activity of orexin receptors is modified. The model has several essential 
features regarding the mechanisms of Meth-evoked hyperthermia and stress response. 
 Both low dose of Meth and stress activate the excitatory component which is mediated by 
orexin receptors and hence can be suppressed by SB. 
 The inhibitory component of the response to Meth is also mediated by orexin. 
 Orexin antagonism disinhibits, and thus increases the sensitivity of the component normally 
activated by the high dose of Meth. 
 Insufficient inhibitory drive can cause fatal hyperthermia after relatively low doses of Meth. 
This insufficiency can be provoked by a decreased orexinergic tone either due to deficiency 
of orexinergic transmission (narcolepsy) or after administration of orexin receptor 
antagonists (e.g. used for drug abuse treatments).  
36 
 
 CIRCADIAN VARIABILITY OF BODY TEMPERATURE CHAPTER 3.
RESPONSES TO METHAMPHETAMINE 
3.1 Introduction 
Vital parameters of living organisms exhibit circadian rhythmicity. Daily variations of body 
temperature in rats may exceed 1
o
C, with body temperature at night being higher than during 
daytime. Accordingly, temperature fluctuations in response to low doses of amphetamines 
appear comparable to daily variations of body temperature: i.p. injection of 1 mg/kg of 
methamphetamine (Meth) increases body temperature by approximately same 1
o
C [1, 17]. 
Intermediate doses of Meth (5 mg/kg, i.p.) evoke a response of similar magnitude, but delayed in 
time [1, 62]. Therefore, it is reasonable to hypothesize that the temperature responses to 
psychostimulants may differ depending on the time of the day. However, despite rats are 
nocturnal animals, most of the studies of drugs of abuse in rodents are performed during the day. 
To the best of our knowledge, this is the first study to describe circadian variability of responses 
to methamphetamine (Meth). 
There is a clear interaction between circadian rhythmicity and effects of amphetamines. First, 
amphetamines induce arousal which could be due to alterations in the neuronal activity 
controlling circadian rhythms. Administration of Meth results in activation of orexin-containing 
neurons [2, 39, 40], which are critical for normal circadian rhythmicity and are activated during 
active phase of day cycle. Chronic use of Meth leads to disruption of normal circadian 
rhythmicity. If Meth is freely provided to rats in the drinking water, they establish an oscillatory 
pattern of activity [63]. Although the period of these oscillations is close to circadian (24-36 h), 
they are independent of the circuits mediating normal circadian rhythmicity, as these oscillations 
also emerge in rats with a lesioned suprachiasmatic nucleus (SCN) [64]. 
To explain the circadian variability of temperature responses to Meth, in this study, we used a 
mathematical model which was previously developed to explain complex, multiphasic responses 
of body temperature to Meth during the daytime [1, 62]. The model is based on the premise that 
body temperature variations after Meth administration have both an excitatory and inhibitory 
drive. The difference in strength between these two signals determines the dynamics of body 
temperature. Using this model, we assimilated the experimentally obtained nighttime 
temperature responses to Meth. Then, we used Bayesian inference analysis to find which 
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parameters of the model are significantly different between phases of the circadian cycle, and 
interpreted the differences we found. 
3.2 Methods and Data Preparation 
To determine temperature responses to Meth three groups of animals were studied in home cages 
at room temperature in rooms with lights on at 8 am and off at 8 pm. In the first group (Meth-1) 
experiments we injected Meth at 1 mg/kg i.p., in the second (Meth-5) 5 mg/kg i.p, and the third 
normal saline. For each group, half of animals were assigned to experiment during light phase 
(i.p. injection between 10 and 11 am), and others were injected at dark (between 10 and 11 pm). 
Each animal received only one injection of Meth. The number of animals in each group was 
chosen so that the amplitude of Meth-induced temperature deviation from the baseline was 
statistically significantly different between the day and night groups.  
3.3 Model Construction 
3.3.1 General Model approach 
Experimental data on dose-dependence of temperature responses to Meth during daytime were 
described with acceptable precision by a mathematical model previously published in. [1]. In 
short, the model consisted of three components: pharmacokinetics describing concentration of 
Meth in the blood after injection; a neural network which had Meth-dependent inputs, and a 
temperature control system driven by a signal from the neural network (Figure ‎3.1). 
We assumed that after the injection the drug was absorbed in the blood from the peritoneum and 
was also simultaneously being eliminated from the blood.  Accordingly, drug concentrations 
were described by the following equations: 
 
 
𝑑[𝑀𝑝]
𝑑𝑡
= −
[𝑀𝑝]
𝜏𝑢
  
        
𝑑[𝑀]
𝑑𝑡
=
[𝑀𝑝]
𝜏𝑢
−
[𝑀]
𝜏𝑑
 
 
(‎3.1) 
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Figure ‎3.1 Schematic of the network mediating the temperature responses to Meth 
suggested by [1] incorporating circadian phase-dependent inputs. Each circle represents a 
neural population. Meth-sensitive populations (see “Meth”-labeled arrows) are modeled 
as an artificial neuron with sigmoidal activation function applied to its input (see text for 
a detailed description). “Circ”-labeled arrows represent circadian phase dependent inputs. 
Exc, excitatory; Inh, inhibitory; HD, high dose; Med, medulla; SPN, sympathetic 
preganglionic neuron; TEMP, temperature. 
 
 
where t is time in minutes, 𝑀𝑝 is the intra-peritoneal drug concentration, and 𝑀 is the blood drug 
concentration (both in mg/kg). [𝑀𝑝] 𝜏𝑢⁄  represents drug absorption with time constant 𝜏𝑢, and 
[𝑀] 𝜏𝑑⁄  represents drug elimination with time constant 𝜏𝑑 . Initial conditions are [𝑀𝑝](0) = 𝑑, 
[𝑀](0) = 0 for injections made at time 0 where d is the dose of the drug administered. System 
(‎3.1) can be solved explicitly as: 
 [𝑀](𝑡) = 𝑑 (
𝜏𝑢
𝜏𝑑
 − 1)
−1
(𝑒−𝑡 𝜏𝑢⁄ − 𝑒−𝑡 𝜏𝑑⁄ )  (‎3.2) 
 
for 𝑡 > 0, and [𝑀](𝑡) = 0 if 𝑡 < 0.  
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In this study, we use exactly the same formalism as in [1] to model the neural circuitry as a feed-
forward artificial neural network. The outputs of Meth-sensitive neural populations are 
calculated as follows: 
 
𝑃𝐸𝑥𝑐(𝑡) = 𝜎(𝑤𝐸𝑥𝑐 · [𝑀](𝑡) + 𝛾𝐸𝑥𝑐) 
𝑃𝐼𝑛ℎ(𝑡) = 𝜎(𝑤𝐼𝑛ℎ · [𝑀](𝑡) + 𝛾𝐼𝑛ℎ)  
 𝑃𝐻𝐷(𝑡) = 𝜎(𝑤𝐻𝐷 · [𝑀](𝑡) + 𝛾𝐻𝐷) 
 
(‎3.3) 
where 𝜎(𝑥) = (1 + tanh𝑥) 2⁄   is a sigmoid activation function, 𝑤𝑖(𝑡) is the sensitivity of 𝑃𝑖(𝑡) 
to Meth, and 𝛾𝑖  is the parameter defining baseline activity of the population 𝑃𝑖 , 
𝑖 ∈ {𝐸𝑥𝑐, 𝐼𝑛ℎ, 𝐻𝐷}. The activity of medullary population Med is described as follows: 
 𝑃𝑀𝑒𝑑(𝑡) = 𝑤𝐸𝑥𝑐→𝑀𝑒𝑑 · 𝑃𝐸𝑥𝑐(𝑡) − 𝑤𝐼𝑛ℎ→𝑀𝑒𝑑 · 𝑃𝐼𝑛ℎ(𝑡) (‎3.4) 
 
where 𝑤𝐸𝑥𝑐→𝑀𝑒𝑑 and 𝑤𝐼𝑛ℎ→𝑀𝑒𝑑 are the weights of the excitatory and inhibitory projections from 
Exc to Med and Inh to Med, respectively. Inframedullary population SPN duplicates the activity 
of Med but is additionally excited by the Meth-sensitive HD population as follows: 
 𝑃𝑆𝑃𝑁(𝑡) = 𝑃𝑀𝑒𝑑(𝑡) + 𝑤𝐻𝐷→𝑆𝑃𝑁 · 𝑃𝐻𝐷(𝑡) + 𝛾𝑆𝑃𝑁 (‎3.5) 
where 𝑤𝐻𝐷→𝑆𝑃𝑁  is the weight of the excitatory projection from HD to SPN, and 𝛾𝑆𝑃𝑁  is the 
activity of SPN in absence of inputs from Med and HD. 
The temperature dynamics is modeled by a first-order linear ODE driven by the SPN signal as 
follows: 
 𝜏𝑇
𝑑𝑇
𝑑𝑡
= 𝑃𝑆𝑃𝑁(𝑡) − (𝑇 − 𝑇0) (‎3.6) 
 
where T is the body temperature in degrees Celsius, 𝜏𝑇 is the time constant of the temperature 
response, and 𝑇0 is the baseline body temperature. See [1] for all parameter values. 
The equilibrium temperature was defined as the temperature at which the right hand side of (‎3.6) 
is equal to zero after Meth is completely washed out. Accordingly, it is a function of baseline 
activities of the nodes which can be calculated as follows. 
 𝑇𝑒𝑞 = 𝑤𝐸𝑥𝑐→𝑀𝑒𝑑𝜎(𝛾𝐸𝑥𝑐) − 𝑤𝐼𝑛ℎ→𝑀𝑒𝑑𝜎(𝛾𝐼𝑛ℎ) + 𝛾𝑆𝑃𝑁 + 𝑇0  (‎3.7) 
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3.3.2 Circadian variability 
The major assumption of the study was that animals have different status of the Meth-response 
system described above during active and inactive phases of the day. Specifically, we assumed 
that the responses are mediated by the same network, but the baseline activity of its nodes may 
be different during the day and at night. Accordingly, we used the experimental datasets we 
obtained for the day and nighttime to estimate the parameters of the model defining baseline 
activities of the nodes, i.e. 𝛾𝐸𝑥𝑐, 𝛾𝐼𝑛ℎ and 𝛾𝑆𝑃𝑁. All other parameters were assumed independent 
of the circadian phase, so we used their values estimated in the original Meth-response study [1]. 
In our model, the baseline activity levels of the nodes are supposed to be defined by synaptic and 
neuromodulatory inputs independent of Meth, so the day vs. night differences in the values of 
parameters 𝛾𝐸𝑥𝑐 , 𝛾𝐼𝑛ℎ  and 𝛾𝑆𝑃𝑁  can be interpreted as circadian-related (changes of) external 
inputs to the network. 
3.3.3 Statistical Estimation for Model’s Parameters 
We used the Bayesian approach for inferring the model parameters. Then, we employed 
statistical analysis to calculate statistical significance of changes in 𝛾𝐸𝑥𝑐 , 𝛾𝐼𝑛ℎ, 𝛾𝑆𝑃𝑁  between 
day and night. To do this, we constructed a corresponding posterior probability density function 
(PDF) of the parameter vector 𝜸 = (𝛾𝐸𝑥𝑐 , 𝛾𝐼𝑛ℎ, 𝛾𝑆𝑃𝑁) . According to Bayes' rule [65], this 
probability distribution is proportional to the probability that an observed temperature time series 
{𝑇𝑖} is produced by our model with the given 𝜸, usually referred to as a likelihood. Assuming 
that the residuals are normally distributed and non-informative priors for the parameters, the 
posterior PDF, 𝑝(𝜸 ∣ {𝑇𝑖,𝑑}), is given by the following formula: 
 𝑝( 𝜸 ∣∣ {𝑇𝑖,𝑑} )~exp {− ∑ ∑
[𝑇𝑖,𝑑 − 𝑇(𝜸, 𝑖, 𝑑)]
2
2𝜎𝑖,𝑑
2
300
𝑖=30
𝑑=1,5
} (‎3.8) 
 
where 𝑇(𝜸, 𝑖, 𝑑) is the temperature calculated by our model at time i for dose d with the given 𝜸. 
𝑇𝑖,𝑑 and 𝜎𝑖,𝑑 are respectively a mean and a standard deviation of the body temperature over a 
corresponding group of animals for dose d at time i by increments of 10 minutes. We used the 
data starting from 30 minutes after the injection when the effect of the stress becomes negligible. 
We used the Markov Chain Monte Carlo (MCMC) approach, specifically the Metropolis-
Hastings algorithm adapted for reconstruction of dynamical systems [5, 51-53, 66, 67], to create 
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a statistical ensemble of points distributed according to the PDF (‎3.8). Once we had the 
ensembles, we calculated mean values and standard errors for the three parameter estimates for 
each combination of time of day and dose of Meth. Then, we used a two-sample t-test to evaluate 
the statistical significance of differences between the groups. P-value < 0.05 was accepted as a 
statistically-significant effect of the daytime on the corresponding parameter of the model. 
3.4 Results 
3.4.1 At night rats have higher body temperature and stronger stress response 
Baseline (initial) body temperature of animals before the injections was 0.8 ºC higher on average 
at night for all groups (Saline, Meth 1 mg/kg, and Meth 5 mg/kg, Figure ‎3.2). The intraperitoneal 
injection of saline evoked a transient increase of the body temperature (Figure ‎3.2 A). This 
increase developed faster and was almost twice as great during the nighttime. The body 
temperature returned to initial values approximately one hour after the injection and did not 
change significantly for the remaining 5 hours after that. 
3.4.2 At night rats exhibit a weaker hyper-thermic response to the 1 mg/kg dose of Meth 
Lower dose of Meth (1 mg/kg) induced monophasic hyperthermia both during the day and at 
night (Figure ‎3.2 B). However, the maximal increase of the temperature was approximately half 
at night compared with the day. The maximal hyperthermia was observed 30 minutes after the 
injection at night while it occurred after 90 minutes during the day.  
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Figure ‎3.2 Experimental data on body temperature responses to i.p. injections of saline 
and two different doses of Meth at night (solid lines) and during the day (dotted lines). 
Data is shown as mean +/- SEM (N = 6). Dashed lines show approximate initial 
temperature. 
 
3.4.3 At night, there is no hyper-thermic response to the intermediate dose of Meth 
Higher dose of Meth (5 mg/kg) when administered during the daytime caused a delayed hyper-
thermic response peaking at approx. 200 min since the injection (Figure ‎3.2 C). In contrast, at 
night, the same dose did not produce hyperthermia. Moreover, the temperature had a clear 
tendency to decrease, which was not observed during the day. 
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Figure ‎3.3 Temperature dynamics as reproduced by the model (solid curves) with 
parameters corresponding to the mode of PDF (8) superimposed on experimental data 
obtained at night (error bars) since 30 min after the injection of 1 mg/kg of Meth (A) and 
5 mg/kg of Meth (B). Chi-square test [68]: sum squared standardized residual, 𝜒2 = 33.4; 
number of degrees of freedom, 𝜈 = 51; p-value = 97%. Coefficients of determination: 
𝑅2 = 0.74  for 1 mg/kg; 𝑅2 = 0.51  for 5 mg/kg. Dashed line shows the equilibrium 
temperature estimate. 
 
3.4.4 At night, the excitatory node has substantially higher baseline activity 
We used model (‎3.1) to fit the above experimental data (see Figure ‎3.3 and its legend for the 
most probable model responses and conventional goodness-of-fit measures).  
Then we sampled the PDF (‎3.8) to estimate parameters 𝛾𝐸𝑥𝑐 , 𝛾𝐼𝑛ℎ, 𝛾𝑆𝑃𝑁  and their standard 
errors during the day and at night (Figure ‎3.4) as described in Methods. We found that at night 
the parameters defining baseline activities of Exc and Inh nodes, 𝛾𝐸𝑥𝑐  and 𝛾𝐼𝑛ℎ , respectively, 
have statistically significantly higher values (Figure ‎3.4 A, B). Specifically, from day to night, 
the drive to excitatory node, 𝛾𝐸𝑥𝑐, changes from about -0.35 to about 0.05 (Figure ‎3.4 A), which 
correspond to an increase in baseline activity of the Exc from approx. 30% to above 50% of 
maximum. The day-to-night change in the drive to the inhibitory node is relatively small from 
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approx. -1.3 to -1.0 (Figure ‎3.4 B) corresponding to the increase in its baseline activity from 
approx. 7% to 12%. Therefore, the baseline activity of the excitatory node is increased to a 
substantially greater extent than of the inhibitory node, which has a net positive effect on the 
baseline activity of the medullary node (see Figure ‎3.1). There was no statistically significant 
difference in 𝛾𝑆𝑃𝑁 values between day and night (Figure ‎3.4 C). 
 
 
Figure ‎3.4 Inferences of circadian phase dependent parameters during the day (light gray) 
and at night (dark gray) shown as mean +/- SD of the posterior PDF (see Methods). * 
denotes statistically significant difference of daytime and nighttime values. 
 
3.4.5 Meth reduces the equilibrium temperature in a dose-independent manner 
As mentioned, during the day the average baseline temperature was approximately 0.8 ºC lower 
than at night. Specifically, the initial temperatures during the day and at night were 37.02 ± 0.04 
ºC vs. 37.81 ± 0.09 ºC, respectively. In rats injected with saline the equilibrium temperature (see 
Eq. (‎3.7)) was equal to the baseline temperature. However, after Meth injections the equilibrium 
temperature appeared to be significantly lower. Specifically, during the day the equilibrium 
temperature was 36.66 ± 0.09 ºC, and at night it was 37.34 ± 0.06 ºC (Figure ‎3.3, Figure ‎3.5). 
Hence, on average, Meth injection caused a statistically significant decrease in the equilibrium 
temperature by 0.36 ºC during the day, and by 0.47 ºC at night. 
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Figure ‎3.5 Estimates of equilibrium temperature for each combination of saline vs. Meth 
and day vs. night. Groups injected with either dose of Meth are pooled together. 
 
To check whether this effect is dose dependent or not, we estimated the parameters 𝛾𝐸𝑥𝑐 , 𝛾𝐼𝑛ℎ,
𝛾𝑆𝑃𝑁  separately for the groups of rats injected with 1 mg/kg and 5 mg/kg of Meth at night 
(Figure ‎3.6). We did not find statistically significant difference between the 2 doses in individual 
parameter values (Figure ‎3.6 A, B, C), as well as in the equilibrium temperatures (Figure ‎3.6 D). 
 
 
Figure ‎3.6 Comparison of circadian phase dependent parameter estimates at night for 
experimental groups injected with 1 mg/kg of Meth (light gray) and 5 mg/kg of Meth (dark 
gray). No statistically significant differences observed. 
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3.5 Discussion 
3.5.1 Mechanisms of circadian variations of Meth responses 
As we previously described in [1, 62], the temperature response to the administration of Meth 
has three distinct components putatively mediated by three distinct neuronal populations/nodes 
(Figure ‎3.1) that have different activation thresholds for Meth, and, hence, get activated at 
different Meth concentration levels.  
The node most sensitive to Meth is labeled Exc in Figure ‎3.1. It is an excitatory node which can 
be activated by a low dose of Meth. This node mediates virtually immediate increase in the body 
temperature after injection of 1 mg/kg during the day (Figure ‎3.2, middle panel, dotted curve). 
By estimating the parameters of the model using the data obtained at night (Figure ‎3.2, two right 
panels) we found that at night the excitatory node has much higher baseline activity (~30% of 
max during the day vs. ~50% of max at night, see also Figure ‎3.3). We speculate that at night the 
corresponding population of neurons receives additional excitatory drive which may be treated as 
circadian rhythm related input. 
Due to saturation, higher baseline activity of the excitatory node leaves less room for this 
population to further increase its activity after Meth injection. Specifically, during the day 70% 
of the maximal activity is still available, while only 50% remains available at night. Accordingly, 
the low dose of Meth (1 mg/kg) additionally activates this population to a lesser extent at night, 
which contributes to the attenuation of hyperthermia following Meth injection (Figure ‎3.2, 
middle panel). 
The intermediate dose of Meth used in our study (5 mg/kg) is sufficient to activate not only the 
excitatory but also the inhibitory node (Figure ‎3.1). During the day, the excitatory and inhibitory 
components are almost level until the concentration of Meth falls below the threshold of the 
inhibitory component activation (see [1] for details). However, at night, due to saturation of the 
excitatory node activity as described above, the inhibitory node starts dominating during the 
initial phase of the response thus causing a transient reduction in temperature (Figure ‎3.4, right 
panel). 
Another mechanism underlying smaller increase of the temperature after the low dose of Meth 
and a slightly hypothermic response to the intermediate dose at night is a reduction in the 
equilibrium temperature after the Meth injection. Since the initial temperature at night appears 
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almost a half degree higher than the equilibrium temperature (37.81 ºC vs. 37.34 ºC, 
respectively), the already weakened effect of the excitatory node activation occurs on the top of 
the declining trend towards the lowered equilibrium temperature. 
3.5.2 Mechanisms of higher baseline temperature at night 
In this study, we found that the excitatory node (Exc) of the neuronal network responsible for 
temperature fluctuations after Meth injections (Figure ‎3.1) has higher baseline activity. 
Specifically, Exc increases its baseline activity from ~30% of max during the day to ~50% at 
night. Such an increase, according to Eq. (‎3.7), would result in ~2ºC increase in temperature. At 
night, the baseline temperature was elevated by 0.8ºC only, so some compensatory mechanisms 
should be involved. In Figure ‎3.3 B one can see that parameter 𝛾𝐼𝑛ℎ, which defines the baseline 
activity of the inhibitory node (see Inh in Figure ‎3.1), is also increased at night. This has a 
negative effect on the equilibrium temperature of about 0.5ºC. The remaining compensation 
(approx. 0.7ºC) must have been provided by other, e.g. thermoregulatory, mechanisms. 
3.5.3 Mechanisms of lower equilibrium temperature after injection of Meth 
We found that after either dose of Meth the equilibrium temperature reduces relative to the 
baseline temperature by 0.36ºC and 0.47ºC during the day and at night, respectively (Figure ‎3.5). 
The equilibrium temperature (as described by Eq. 7) depends on baseline activities of three 
nodes in the network, 𝜎(𝛾𝐸𝑥𝑐), 𝜎(𝛾𝐼𝑛ℎ) and 𝛾𝑆𝑃𝑁. Accordingly, the reduction in the equilibrium 
temperature can result from either lower 𝜎(𝛾𝐸𝑥𝑐) and/or 𝛾𝑆𝑃𝑁, or higher 𝜎(𝛾𝐼𝑛ℎ). Unfortunately, 
for obvious reasons it is impossible to infer these quantities in our experimental paradigm 
without injecting Meth. However, we can speculate that by design of the model, the dependence 
of Exc and Inhib nodes on Meth concentration is already explicitly described by Eq. (‎3.3), and 
the reduction in equilibrium temperature occurs due to long lasting alterations in the 
thermoregulatory system manifesting themselves by a reduction in 𝛾𝑆𝑃𝑁.  
3.5.4 Putative neuronal structures and neurotransmission 
The original model was based on existing but rather limited experimental identification of 
structures responsible for temperature variations after Meth injections [1]. We speculated that the 
excitatory component (Exc node in Figure ‎3.1) of the response is mediated by dorsomedial 
hypothalamus (DMH) which projects to the pre-sympathetic neurons in the ventromedial 
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medullary region (raphe pallidus, Med node) relaying the signal further down to sympathetic 
preganglionic neurons in the spinal cord (SPN node). The inhibitory drive (Inh) putatively 
originates from supramedullary (preoptic nucleus or ventrolateral PAG) and/or intramedullary 
(rostro-ventral lateral medulla) structures. 
Previously we demonstrated that temperature responses to Meth are mediated by orexinergic 
neurotransmission [2]. Moreover, using the mathematical model [1] we inferred that both the 
excitatory and inhibitory components are likely to be activated by orexinergic signals induced by 
Meth administration. In the present study, we show that at night the excitatory and inhibitory 
nodes receive additional drive. Importantly, the night is an active time for rats when orexinergic 
neurons are firing. Therefore, it is reasonable to suggest that additional drive to the excitatory 
and inhibitory nodes emerging at night is orexinergic. This suggestion leads to an interesting 
prediction. We previously reported that blockade of orexinergic neurotransmission during the 
day did not evoke any thermal responses by itself [2]. However, at night, when the status of the 
thermoregulatory network is modulated by orexinergic inputs, the same manipulation should lead 
to significant body temperature variations. 
3.6 Conclusions 
In this study, we were the first to measure and compare the body temperature responses in rats to 
injections of Meth during daytime and at night. We found that at night, which is their active time 
of the day, rats exhibit much weaker temperature fluctuations after Meth administration as 
compared to their time of rest.  
Using mathematical modeling, we inferred that at night the neuronal circuitry mediating thermal 
responses to Meth receives additional excitatory inputs primarily converging at the excitatory 
node which has the lowest activation threshold to Meth. These inputs substantially increase the 
baseline activity of this node. Therefore, its additional activation after Meth administration at 
night turns out to be much weaker compared to the daytime because of saturation.   
Furthermore, we observed that in the long run the temperature tends to stabilize at lower levels 
after Meth washes out. This reduction in the equilibrium temperature was similar for both doses 
of Meth used in this study, and was substantially stronger at night, which further reduced 
hyperthermia and exaggerated hypothermic components of the response. 
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 EXERCISE ACTIVATES COMPENSATORY CHAPTER 4.
THERMOREGULATORY REACTION IN RATS: A MODELING 
STUDY                                                                                                   
4.1 Introduction 
To compensate for overall life style-induced decrease of exercise [69], millions of people around 
the world participate in various sports. Many of these people choose to exercise and compete 
outdoors. Since outdoor running occurs most frequently in the warmer months of the year, the 
participants are at risk for developing heat-related illnesses. 
The most devastating heat-related illness is exertional heat stroke. Occurring in otherwise 
healthy people, heat stroke affects people at the most productive times of their lives. Between 
1990 and 2010 an average of 2 high school and college football players died each year due to 
heat stroke [70]. The US Centers for Disease Control estimate that each year 660 heat related 
deaths occur [71]. Along with the risk for death, those suffering heat stroke lose the ability to 
work or perform normal activities and may suffer life-long medical complications even after 
recovery. As the number of marathoners in USA exceeds a half a million [72], the ability to 
predict who is prone to heat stroke could benefit thousands of people. The dynamics of the body 
temperature is a major determinant of a heat stroke [73], so the ability to predict a heat stroke is 
largely an ability to predict changes in body temperature. 
Mammals have developed multiple thermoregulatory mechanisms to maintain their core body 
temperature within a relatively narrow range. In cold environments, the body produces heat 
through non-shivering thermogenesis and decreases heat dissipation through cutaneous 
vasoconstriction [6]. Correspondingly, in warm environments, non-shivering thermogenesis is 
shut off and excess heat is dissipated by increasing blood flow near the skin and, in humans, 
through evaporative heat loss through sweat. 
During exercise an additional heat is produced by contractions of the skeletal muscles. Unlike 
“classical” heat stroke where the primary cause of heat stroke is ineffective dissipation of heat in 
hot and/or humid environment, exertional heat stroke develops due to excessive production of 
heat from work/exercise. In these cases, heat stroke is produced by heat production outstripping 
maximal heat dissipation. It is logical to hypothesize that during exercise heat production 
unrelated to exercise would be suppressed (for review see [74]). However, activity-
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thermoregulatory heat substitution had not been analyzed in terms of resulting body temperature 
dynamics. Thermoregulatory processes affecting heat production during exercise are difficult to 
study, as the corresponding experimental paradigms require measuring the metabolism in, and 
heat exchange between, different body compartments in conscious running animals. In this study, 
we use mathematical modeling to characterize thermoregulatory processes from easy to measure 
body temperature dynamics observed at different ambient temperatures and exercise intensities. 
4.2 Methods and Data Preparation 
Two series of experiments were performed in two separate groups of rats – running at room 
temperature (𝑇𝑎 =25
o
C, N=6) and running at high ambient temperature (𝑇𝑎 =32
o
C, N=4). Each 
rat was subjected to four experiments: either had run on the treadmill at one of three speeds (6, 
12 and 18 m/min with zero incline) or had stayed on the idle treadmill belt (0 m/min with zero 
incline).  
4.3 Model Construction 
4.3.1 General Model Design 
The time constant of telemetric probe measured by us was relatively small (0.96±0.01 min), 
which allowed us to neglect the inertia of measurements in the model. 
In a model containing only one compartment any additional heat production due to running will 
result in immediate increase of body temperature. This contradicts the dynamics of body 
temperature in first minutes after an initiation of running, when body temperature does not 
change or can even slightly decrease. Therefore, we excluded one compartment models from 
further consideration. 
Our working mathematical model contained two compartments which generate heat aptly named 
core body and muscles. We considered that muscles perform the physical work, and are 
producing heat during exercise. Muscles are insulated from environment, and as such can 
dissipate heat only to the core. Biologically we expect the heat generated by the muscles to be 
transferred to the core proportionately to the difference of temperature between the two 
compartments. In turn changes of heat production in the core are not a direct result of performing 
the physical work, and are of regulatory origin. The core can also dissipate heat to the 
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environment with heat loss proportionate to the difference between core body and ambient 
temperatures.  
In rats, the bones and muscles together constitute 45-50%  of body weight [75], while skeleton 
comprises only approximately 3% [76]. Therefore, we explicitly assumed that two compartments 
of the model (core body and muscles) have equal heat capacities. We introduced net heat 
accumulation in the core 𝑃0 as the difference between overall heat production in the core and 
dissipation to the environment. We assumed that at rest all heat to be generated in the core. 
Based on the experimental data [77] the temperature of the muscles was considered equal to the 
temperature of the core without exercise as an initial condition.  𝑃𝑚 was defined as the additional 
heat produced by the muscles due to exertion. Both 𝑃0  and 𝑃𝑚 were considered constant 
throughout exercise. Initial model fitting was performed by varying the parameters 𝑃0 and 𝑃𝑚 in 
order to check the basic validity and the ability to reproduce experimental data.   
Differential equations describing the change in temperature for each compartment were written 
as follows.  The rate of change in the temperature of the core over time (𝑑𝑇𝑐/𝑑𝑡, °𝐶/𝑚𝑖𝑛) is 
affected by the net heat accumulation in the body and the heat transfer from muscles. 
 
𝑑𝑇𝑐
𝑑𝑡
= 𝑃0 + 𝜂(𝑇𝑚 − 𝑇𝑐) (‎4.1) 
 
where 𝜂 is a heat transfer coefficient, which indicates the percent of temperature differential 
transferred from the muscles to the core per minute and measured in 𝑚𝑖𝑛−1.  We found that  
𝜂 = 0.125 𝑚𝑖𝑛−1  provided an average value of the rate of heat transfer, which best reproduced 
the data. 
Correspondingly, the rate of change in temperature of the muscles (𝑑𝑇𝑚/𝑑𝑡, °𝐶/𝑚𝑖𝑛)  was 
affected by heat produced due to running and heat exchange with the core. 
 
𝑑𝑇𝑚
𝑑𝑡
= 𝑃𝑚 − 𝜂(𝑇𝑚 − 𝑇𝑐) (‎4.2) 
 
At equilibrium we know that the temperature is not changing indicating that  
 𝑑𝑇𝑐/𝑑𝑡 = 𝑑𝑇𝑚/𝑑𝑡 =  0 (‎4.3) 
 
At initial resting conditions, there is no additional heat generated by exercise, 𝑃𝑚 = 0, and the 
net heat accumulation in the core 𝑃0 = 0. To satisfy condition (‎4.3) and considering resting 
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conditions we set the initial temperature of the muscles equal to the initial temperature of the 
core 𝑇𝑚(0) = 𝑇𝑐(0) = 𝑇0.  This temperature is higher than ambient temperature due to baseline 
heat production by the organism.  Any baseline heat production in muscles before the exercise is 
considered as a part of the 𝑃0, while the 𝑃𝑚 reflects only the heat produced from exercise. 
The explicit solution of the system of equations can be found for any given time 𝑡 as: 
 
 𝑇𝑐 = 𝑇0 + 𝑃0 (
𝑡
2
+
1 − 𝑒−2𝜂𝑡
4𝜂
) + 𝑃𝑚 (
𝑡
2
−
1 − 𝑒−2𝜂𝑡
4𝜂
) (‎4.4) 
 
 𝑇𝑚 = 𝑇0 + 𝑃0 (
𝑡
2
−
1 − 𝑒−2𝜂𝑡
4𝜂
) + 𝑃𝑚 (
𝑡
2
+
1 − 𝑒−2𝜂𝑡
4𝜂
) (‎4.5) 
 
4.3.2 Model Parameter Estimation 
A temperature time-series for each running speed at each ambient temperature consisted of 16 
points for each rat (15 min running), which were calculated by obtaining medians for 
corresponding time intervals as described in Data Processing. For each ambient temperature 𝑇𝑎 
and speed 𝑗 we calculated the mean temperature among rats at time t at  as {𝑇𝑡
𝑗}
𝑡=0
15
 . Also, we 
denote the predicted value of 𝑇𝑐 from our model using [4] at time 𝑡 as 𝑇(𝑃0, 𝑃𝑚 , 𝑇0, 𝑡).  
For a fixed speed 𝑗 , we considered, 𝑇𝑡
𝑗
,of the time series {𝑇𝑡
𝑗}
𝑡=0
15
 as independent identically 
distributed normal random variables with mean 𝑇(𝑃0, 𝑃𝑚, 𝑇0, 𝑡) and variance 𝜎
2 = ∑ 𝑠𝑡
215
𝑡=0 /16,  
where 𝑠𝑡
2 is the sample variance found for each time t=0,1…,15,  i.e. 𝑇𝑡
𝑗~𝑁(𝑇(𝑃0, 𝑃𝑚 , 𝑇0, 𝑡), 𝜎
2). 
Then, the likelihood function, the conditional joint probability density function, is given by the 
product of the conditional distributions as noted: ∏ 𝑓({𝑇𝑡
𝑗}𝑡=0
15 |𝑇0, 𝑃0, 𝑃𝑚
15
𝑡=0 ).  The likelihood 
function can be calculated as recommended in [1, 52, 78]: 
𝐿({𝑇𝑡
𝑗}𝑡=0
15 |𝑇0, 𝑃0, 𝑃𝑚) =
1
(2𝜋)
16
2 𝜎16
exp {−
1
2𝜎2
∑ (𝑇𝑡
𝑗 − 𝑇(𝑃0, 𝑃𝑚 , 𝑇0, 𝑡))
2
15
𝑡=0
} (‎4.6) 
where 𝑗 = 0, 6, 12, 18 (𝑚/𝑚𝑖𝑛).  
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4.3.3 Model Reduction and Analysis 
By maximizing the likelihood (‎4.6) we obtained a best-fit set of parameter values (𝑃0, 𝑃𝑚, 𝑇0) for 
each speed at two different ambient temperatures, 25°𝐶 and 32°𝐶. Then by assuming that the 
likelihood (‎4.6) represents a Bayesian posterior probability distribution for the model parameters, 
we calculated the 95% confidence regions of parameter estimates on the (𝑃0, 𝑃𝑚)-plane, which 
demonstrated strong negative correlation between estimates of these two parameters. This 
correlation results in large variability of estimate for individual parameters. This also indicated 
that any independent prior limitations on the value of one of the parameters could significantly 
improve the precision of the estimates for both of them. 
To formulate the prior restrictions on the parameters, we considered two hypotheses. First, we 
hypothesized that the heat production in the core at high ambient temperature is at its minimum, 
and hence cannot be further lowered by exercise, while heat dissipation remains constant. 
Mathematically this means that the net heat production in the core 𝑃0  at 𝑇𝑎 = 32 °𝐶  remains 
equal to 0 for all treadmill speeds. The statistical analysis confirmed that the estimate for 𝑃0 is 
not statistically significantly different from 0 for any speed. Second, we hypothesized that the 
heat production in the muscles 𝑃𝑚 is independent of 𝑇𝑎 and depends only on the intensity of the 
exercise (speed of the treadmill). Following these hypotheses, at 𝑇𝑎 = 32 °𝐶, we fixed 𝑃0 = 0 
for all speeds, and used the likelihood function to determine the best-fit 𝑃𝑚 values for each speed. 
Then, these 𝑃𝑚 values were substituted into the model for 𝑇𝑎 = 25°𝐶, which was used to obtain 
the distribution of 𝑃0 values for different speeds at 25°𝐶.  
4.4 Results 
4.4.1 Body Temperature Dynamics 
All rats were kept in home cages at room temperature before being placed on the treadmill. The 
time during which the baseline temperature was recorded was sufficient to achieve uniform 
values of core body temperature in all groups within 37.3±0.2
o
C. No statistical differences 
between baseline temperatures in all experiments (for various ambient temperatures and speeds)  
were found.  The dynamics of the average temperature for each group is shown in Figure ‎4.1. 
The temperature in all groups eventually rose, including animals on the idle belt (Figure ‎4.1, 0 
m/min).  In a room temperature environment 𝑇𝑎 = 25°𝐶  the core temperature decreased slightly 
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before starting to rise; this decrease was observed at all running speeds (Figure ‎4.1 A). In the 
warm environment, 𝑇𝑎 = 32°𝐶 , the body temperature did not decrease initially, however the 
temperature did not start to increase for at least 3 min (Figure ‎4.1 B). After 5 min body 
temperatures were increasing in a linear fashion in all groups until the end of the run (15 min 
total, Figure ‎4.1 A, B). 
 
 
Figure ‎4.1 Experimental data: the average and standard deviations of the core body 
temperature of rats running on a treadmill for 15 min at various speeds in two environments – 
(A) at 25
o
C and (B) at 32
o
C. Rats were in their home cages before the run, transferred to the 
treadmill at t=0 min, and the belt was set to the actual speed in 30 sec. 
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The presence of a “hypothermic” phase is more obvious when experimental data for both 
ambient temperatures are plotted together (Figure ‎4.2A). We have used the estimate of the rate of 
change in the core temperature from 6 to 11 minutes to determine the rate of heat accumulation. 
In the control group which was placed on an idle treadmill, the rate of change of the core 
temperature was almost identical for both ambient temperatures (Figure ‎4.2B). However, at 25°𝐶  
running at the speed of 18 m/min subtly increased the rate of heat accumulation, whereas at 32
o
 
C running at 18 m/min led to almost two-fold faster increase in temperature (Figure ‎4.2 B). 
After analysis of the experimental data we can summarize a few qualitative observations and 
phenomena characterizing short-term running on a treadmill as follows. First, the running at the 
treadmill results in increases in body temperatures which do not appear immediately, but rather 
after a delay. Second, increases in temperature are preceded by slight decreases at room 
temperature, while no initial change in temperature is observed in the warm environment. Finally, 
the rate of heat accumulation is not significantly different between animals running with 
different speeds at room temperatures. In a warm environment, however, the increase in the 
running speed correlates with the rate of heat accumulation. 
 
 
Figure ‎4.2 Comparison of the body temperature dynamics (A) and heat accumulation rate 
(B) between animals at two ambient temperatures which were either running at 18 m/min 
or staying on the idle belt. Heat accumulation rate was calculated as an average rate of 
the body temperature change between 6 and 11 min. * indicates statistically significant 
difference with staying on the idle belt (p<0.05). 
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4.4.2 The model with unrestricted parameter values 
At first, we utilized the likelihood function [6] to find the confidence regions for all model 
parameters in all groups as described in Methods section. The analytically calculated (for the 
high ambient temperature) 95% confidence regions on the (𝑃𝑚, 𝑃0)-parameter plane have an 
elliptical shape and are shown on Figure ‎4.3 A.  Figure ‎4.3 B and C represent the best-fit 
estimates and standard errors for 𝑃0 and 𝑃𝑚 respectively. 
The 𝑃0  and 𝑃𝑚  estimates appear strongly correlated. This suggests that the model with 
unrestricted parameter values is overdetermined. Practically, it means that the model with higher 
heat production in the muscles and accordingly lower net heat production in the core can 
describe the same temperature curve equally well. Consequently, while the ellipses in Figure ‎4.3 
A are largely separated, their projections onto 𝑃𝑚 and 𝑃0 axes (which represent the confidence 
intervals for each parameter individually) heavily overlap. Accordingly, no conclusion can be 
drawn about exercise intensity dependent changes in individual parameters, as those changes 
appear statistically insignificant due to large standard errors. The standard approach to overcome 
the problem of the overdetermined model is to introduce appropriate prior restrictions on its 
parameter values.  We formulated two biologically plausible hypotheses and verified that none of 
them contradicted our modeling results with unrestricted parameter values.  
First, Figure ‎4.3 B shows that at room temperature 𝑃0 drops to negative values for all speeds, 
whereas this is not observed in warm environment. Such drop in 𝑃0 represents a decrease in the 
core metabolism. With an increase in ambient temperature, the core metabolism is decreasing to 
maintain the appropriate body temperature until metabolism reaches a minimum value. Our first 
hypothesis is that at  𝑇𝑎 = 32°𝐶 this limit is reached, and accordingly the exercise cannot lead to 
any further thermoregulatory decrease in the core heat production. Mathematically, this 
hypothesis states that for all speeds at high ambient temperature 𝑃0 remains equal to 0. Statistical 
analysis indeed shows that at  𝑇𝑎 = 32°𝐶 , none of the 𝑃0  estimates for different speeds are 
statistically different from 0. This fact is reflected in Figure ‎4.3 A as confidence regions of 𝑃0 for 
each speed contained 𝑃0 = 0. Our second hypothesis follows that the heat production in the 
muscles correlates with exercise and its intensity, and does not depend on the ambient 
temperature. In support of this idea no statistically significant differences were found between 
𝑃𝑚 values for different ambient temperatures, at identical treadmill speeds (Figure ‎4.3 C). 
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Figure ‎4.3 (A) Confidence regions on the (𝑃0, 𝑃𝑚)-plane for each of the four studied 
speeds (0, 6, 12, and 18 m/min) at 32 
o
C; B-C:  Parameter estimates before the model 
reduction for two ambient temperature, 25°𝐶 and 32°𝐶: (B) 𝑃0 vs speed, (C) 𝑃𝑚 vs speed; 
D-E: Parameter estimates after model reduction: (D) 𝑃𝑚 vs speed at 𝑇𝑎 =32°𝐶 after 𝑃0 is 
set to 0 for the experiments at 32 °𝐶, (E) 𝑃0 estimates at different speeds of running at 
25
o
C with  𝑃𝑚  values from panel D under an assumption that heat generation in the 
muscles does not depend on the ambient temperature. 
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4.4.3 The restricted model 
The first condition which we applied to the model was fixing 𝑃0 = 0  at the high ambient 
temperature. As expected, this restriction allowed calculation of 𝑃𝑚 with much better precision 
(Figure ‎4.3D). Increasing the treadmill speed resulted in progressive increases in heat production 
by the muscles. Interestingly, just placing an animal on the treadmill resulted in heat production 
in the muscles comparable to the non-zero speeds. Specifically, the heat production at zero speed 
is approximately one half of the heat produced at the highest running speed of 18 m/min.  
Following the second hypothesis that 𝑃𝑚depends on speed, but not on ambient temperature, we 
used the 𝑃𝑚 values shown in Figure ‎4.3D to define changes of 𝑃0 for the ambient temperature 
 𝑇𝑎 = 25°𝐶 (Figure ‎4.3 E). Overall, the model reproduced experimental temperature dynamics: 
calculated values were within standard deviations (Figure ‎4.4). The dynamics of the predicted 
temperature of the muscles is shown at the Figure ‎4.5.  
Placing the animal on a treadmill (speed 0 m/min) resulted in a small but significant decrease of 
core heat production. As the running speed increased the decrease in core heat production 
became more significant. This decrease was not able to fully compensate for the production of 
heat in muscles. At the highest running speed, the increase in muscle heat generation was 
approximately 0.4 
o
C/min, while 𝑃0  dropped by only 0.1
 o
C/min. The difference between 𝑃𝑚 
values for 0 and 18 m/min was appr. 0.2
o
C/min. This resulted in significant increases in overall 
heat accumulation at the ambient temperature of 32
o
C (Figure ‎4.2 B). At room temperature the 
heat produced by muscles was half-compensated by the reduced core heat generation. This led to 
an increase in heat accumulation to be not significant (Figure ‎4.2 B).  
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Figure ‎4.4 Comparison of the experimental data (error bars) and the core temperature 
curves as generated by the model (solid lines) using the parameter estimates represented 
in Fig. 3D,E. The error bars show the mean ± one standard deviation of the core body 
temperature over a group of rats. Rows of graphs correspond to different speeds of 
running (A,E: 0 m/min, B,F: 6 m/min,  C,G: 12 m/min and D,H: 18 m/min as marked on 
the left). Columns of graphs correspond to different ambient temperatures (25
o
C, first 
column; 32
o
C, second column). 
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Figure ‎4.5 Muscle temperatures as predicted by the model. (A) at 𝑇𝑎 = 25 °𝐶  (B) at 
𝑇𝑎 = 32 °𝐶. 
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4.5 Discussion 
4.5.1 Overview 
Treadmill exercise results in the steady production of heat in animals [79]. Our objective was to 
mathematically model core body temperature changes as a result of exercise as a first step in 
building a model to predict the expected core body temperature at any given point in time given 
a specific running speed and ambient temperature. We also attempted to model physiologic and 
metabolic responses, which are difficult to directly measure in exercising animals: muscle 
temperature, and both muscle and core heat generation.  
4.5.2 Relationship between various parameters characterizing heat production 
Temperature changes in the body occur because metabolic processes generate heat. Increases in 
temperature occur when heat production is greater than dissipation into the environment, and 
decreases occur when it is less. In our model, heat production is separated into exercise-related, 
which occurs in muscles (𝑃𝑚), and exercise-independent, which we assume to occur in the core. 
The heat production in the core was combined with the heat dissipation from the core indicating 
overall net heat change in the core and it was quantified as 𝑃0.   
Heat generation and dissipation is commonly expressed as power (P, energy divided by time) 
and is measured in units of energy per unit of time (e.g. Watt=Joule/sec). Heat accumulation is 
directly connected with changes in body temperature through heat capacity as dT/dt=P/Heat 
Capacity [80]. Both heat production during running and heat capacity are proportional to the 
body weight, therefore changes of body temperature are independent of body weight and are 
reflecting heat production per unit of weight. In this manuscript the heat production/ 
accumulation is always expressed in 
o
C/min which can be translated to the power by multiplying 
by the heat capacity of the body. 
As it will be discussed below, we accepted heat dissipation approximately constant throughout 
these experiments, because the body temperature is not changed strongly enough to activate 
thermoregulatory responses. Therefore, 𝑃0  provides an estimate of the changes in heat 
production mediated by the core, and a sum (𝑃0 + 𝑃𝑚) can be considered an estimate of a change 
in total heat production in the organism. 
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At room temperature rats can run at the maximal speed used in this study, 18 m/min, for 
extended periods of time. We have noticed that rats will run for more than an hour at room 
temperature (unpublished observation). This means that at this speed, heat is generated by 
oxidative processes without significant accumulation of metabolic byproducts such as lactic acid. 
In this case the generated heat is proportional to oxygen consumption, because the differences 
related to metabolic substrate comprise less than 7% per unit of oxygen: if the substrate is 
carbohydrates, the energy generated from one liter of O2 is 21.13 kJ, and it is 19.69 kJ if the 
substrate is fat [81]. Considering this, in the following discussion we will draw connections 
between studies that used various end-points – body temperature, heat production or oxygen 
consumption. 
Via modeling, we have quantified several key phenomena. While some of those phenomena may 
appear counterintuitive, we found multiple evidences supporting our observations.  
4.5.3 Delay in body temperature increase 
When animals began running, their body temperature did not increase immediately. Instead there 
was a several minute long delay prior to the temperature elevation. Even more, there was a 
decrease in the temperature observed at the beginning of the run at room temperature. A graph of 
abdominal temperature versus running time revealed a delay in the temperature change at the 
beginning of the run in the study by Fuller et al. [82]. Hasegawa et al [83] also observed a 
similar delay: when a rat was transferred from a home cage to an idle treadmill, there were at 
least two data points, shown in 5 min time increments, before the slope of the temperature curve 
became positive (see Fig. 2 in [83]). Upon activation of a treadmill, there was an immediate 
temperature increase, however, there was a 10 min delay prior to reaching the maximum slope 
[83]. In a separate study from the same group a similar delay was shown (see Fig. 2 in [84]).   
The mechanism of this delay at the beginning of run is explained by our model. As soon as 
exercise begins, contracting muscles begin to produce heat, yet this heat is not transmitted to the 
core immediately. Until muscles become physically warmer than the core, there is no net transfer 
of the heat to the core, and no changes in the core body temperature occur. The rate of heat 
transfer from the muscles to the core is proportional to the difference in temperatures between 
the core and the muscles and the heat transfer coefficient 𝜂 which defines the inertia of this 
process. Therefore, the delay in the core temperature increase is concerned with the time needed 
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for sufficient heat accumulation in muscles to activate the heat transfer from muscles to the core. 
When a larger time scale (1 h or longer) is considered, this delay would be hardly noticeable; 
however, on a time scale of 15 min, this delay is an important part of the system’s dynamics.   
4.5.4 A decrease in temperature in the beginning of the run at room temperature 
A slight decrease in body temperature in the beginning of each run was clearly present at room 
temperature; this was absent at high ambient temperature. We speculate that the mechanism of 
this “hypothermia” may be a compensatory adjustment of heat production in the body core, 
which is not yet compensated by heat transfer from the muscles. It takes some time for the 
produced heat to increase temperature of the muscles, and only after that additional heat can be 
transferred to the core. During this time, the heat produced in the core by the decrease of heat 
accumulation is less than the amount of heat dissipated to the environment. This results in a 
transient decrease of the body temperature. That decrease is significantly smaller or nonexistent 
in hot environments due to low baseline heat production and a smaller difference between the 
temperatures of the environment and the core. An anticipatory decrease of heat accumulation in 
the core occurs at all speeds including 0. So the very fact of the transfer of an animal to the 
treadmill evokes preparation for the exercise. 
4.5.5 Relative independence of body temperature changes on exercise intensity at room 
temperature                                                                                                                 
This phenomenon is best demonstrated by linear increase in body temperature in graded exercise 
studies. An experimental protocol of Balthazar et al. [85] had initial speed of 10 m/min with 5% 
incline and increased the speed every 3 min by 1 m/min. In this protocol of graded exercise body 
temperature increases were virtually linear. Despite increasing speed (the maximal speed was 16 
m/min) the increase of body temperature was so close to linear that the authors calculated the 
average slope over the whole run.  The rate of change of the body temperature measured by 
Hasegawa et al. [86] was also independent of the work load with speeds between 10 and 26 
m/min (see Fig. 1 in [86]).   
In experiments presented in this manuscript, during the linear part of the temperature increase the 
slope of heat accumulation in rats running at 18 m/min is significantly higher than in rats on the 
idle belt of the treadmill in hot environment but not at room temperature (Figure ‎4.2 B). This 
slope is dependent on both 𝑃0 and 𝑃𝑚  with (𝑃0 + 𝑃𝑚/2) providing a good estimate. At high 
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ambient temperatures 𝑃0 = 0 and cannot be decreased with increasing speed. Accordingly, the 
slope increases as 𝑃𝑚 increases (Figure ‎4.3 D). As a result, the slope is higher in running rats 
compared with idle rats (Figure ‎4.2 B). In contrast, at room temperature, 𝑃0 decreases with the 
increasing speed (Fig. 3E), while 𝑃𝑚  has the same dependence on the speed as in the hot 
environment. This means that at room temperature an increase of the temperature slope with an 
increase in treadmill speed is partially offset by decreasing heat accumulation in the core 
(Figure ‎4.2). As a result, due to variability present in all biological systems, the increase in the 
slope does not reach statistical significance (Figure ‎4.2 B). 
At the first glance, this independence contradicts not only common sense, but also experimental 
data demonstrating that at higher speeds body temperatures of rats are higher (see, for example, 
[87]). To interpret this contradiction, it is important to consider a time frame of the experiments: 
Tanaka et al. [87] explicitly stated that they measured the rectal temperature at the steady state 
(after 30 min of running). As shown in the referenced manuscript, in the beginning of the run the 
cutaneous dissipation of heat is not effective, and body temperature increases due to increased 
heat production. As soon as body temperature reaches cutaneous vasodilation threshold, the 
steady state is established. In other words, the steady state is defined by a thermoregulatory 
threshold of cutaneous vasodilation, which is increasing with the running speed. Correlation 
between thermoregulatory threshold and running speed is the reason of higher body temperature 
at higher speeds. We argue below that in the time frame of our experiments the thermoregulatory 
heat dissipation is not activated. 
Alternatively, in studies showing initial phases of temperature increases in rats running at various 
speeds, the slopes of temperature are impressively similar (Figs. 2 and 6 in [88]). Even more, in 
the study of Kunstetter et al. [88] despite initial phases are similar, the temperature dynamics in 
different groups separates dramatically when thermoregulatory heat loss responses are activated 
after the (brain) temperature exceeds heat dissipation threshold.  
4.5.6 Transfer to a treadmill accounts for a large part of temperature change during exercise 
When animals were placed on a treadmill and stayed at least 30 min, Hasegawa et al. [83] found 
that their body temperature rose by 1 
o
C and remained elevated without any trend to return to 
baseline. After stabilization of the increased temperature, running at 10 m/min raised the 
temperature by an additional 0.5 
o
C in 15 min when it again reached a plateau. So placing the 
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animal on the idle treadmill accounted for approximately 2/3 of total increase of the body 
temperature. From equations [2, 3] it follows that the additional overall heat accumulation 
(𝑃0 + 𝑃𝑚 in our study) is proportional to the change in equilibrium temperature after sufficient 
time. The sum ( 𝑃0 + 𝑃𝑚 ) when staying on the idle belt was about 0.17 
o
C/min (see 
Figure ‎4.3D,E), while at a treadmill speed of 12 m/min (closest to the speed used  in [83]) it is 
approximately 0.25 
o
C/min, so a transfer to the belt accounts for approximately the same 2/3 of 
the increase in the rate of heat accumulation in the whole body during running at 12 m/min. 
Further increases in speed do not dramatically increase heat production. Brooks & White [89] 
reported that oxygen consumption was 50 ml/kg/min when running at 15 m/min speed on a 
treadmill with 1% incline, and increased only to approximately 65 ml/kg/min at 45 m/min with 
the same incline.  
4.5.7 Suppression of thermoregulatory metabolism by exercise 
In our study we showed that rats exposed to exercise exhibited a decrease in their core heat 
production. Similar effects of thermoregulation suppression were described in the study by 
Guimaraes et al. [90]. When rats were exposed to 12
o
C, their core body temperature went up (a 
well-known phenomenon from other studies [91]). However, when the animals were forced to 
run at the same temperature, their body temperature was lower than at rest. Running at 
progressively colder temperatures resulted in lower body temperatures at equilibrium, which 
were achieved after 15-30 min of exercise. Similar observations were presented in [92]. 
Assuming that running produces the same amount of heat regardless of the ambient temperature, 
one can conclude that in colder environment the exercise suppresses the thermoregulatory heat 
production more in absolute values. In fact, Makinen et al. [93] observed that exercise did not 
increase oxygen consumption in rats exposed to 0
o
C, which means that intense thermoregulatory 
heat production was substituted by thermogenesis induced by exercise. 
4.5.8 Two compartments are necessary to explain complex temperature dynamics 
In a model with a single compartment, the increase of heat generation would result in an 
immediate growth of the body temperature. In contrast, we observed a clear delay between the 
beginning of an exercise and the temperature rise. Therefore, a single compartmental model is 
not able to accurately describe changes in body temperature during running. 
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It appears that a two-compartment model reproduces experimental data with sufficient level of 
precision. For simplicity sake we named the additional heat produced from exercise as the heat 
produced by muscles, 𝑃𝑚. It is important to note that this variable can include heat produced by 
other organs as well (e.g., the heart or brain), and disregards any heat produced by the muscles at 
rest. In fact, an immediate increase of brain temperature during exercise [92, 94] is a feature of 
“muscle temperature” in our model, and indicates that additional heat production in the brain 
during the exercise contributes to the “muscle” compartment of our model. The rate of the initial 
temperature change in the second compartment (the core) is defined by the difference between 
overall heat production in the core and dissipation to the environment, 𝑃0. In the later times, 
temperature change in the core will be also modified by heat transfer from warmer “muscles”. 
Note again that the use of 𝑃0 is a simplification to refer to any heat produced by the body that is 
not directly related to additional heat resulting from exercise. It also allows us to disregard 
different forms of heat dissipation from the body by combining them in a single term.  
4.5.9 Prior restrictions on model parameters 
Parameter confidence regions on the (𝑃0, 𝑃𝑚) plane appeared to be ellipses strongly extended in 
a certain direction (see Figure ‎4.3 A) providing an indication that the model is underdetermined. 
As a result, the model parameter estimates had large standard errors and, hence, did not differ 
statistically significantly between various speeds and ambient temperatures. As described in the 
methods, our findings became much more conclusive when additional restrictions were applied.  
Two reasonable hypotheses were formulated and proved to not contradict to the initial estimates 
of the parameters of the model. First, we hypothesized that in hot environment there was no 
room to decrease heat generation in the core, supported by the fact that 95% 𝑃0  confidence 
regions for each speed in 𝑇𝑎 = 32°𝐶 included 0 (Figure ‎4.3A). Therefore, we assumed that the 
amount of heat generated in the core body was at its minimum level and it could not be further 
reduced to compensate the additional heat coming from the muscles. This hypothesis is firmly 
footed in the concept of a thermoneutral zone (TNZ). 𝑇𝑎 = 32°𝐶 is just exceeding the estimate of 
the upper border of the TNZ for rats [6]. This means that at 𝑇𝑎 = 32°𝐶, the rat does not generate 
heat to keep its core temperature steady. Instead the only heat that the rat generates is in the 
process of sustaining normal bodily functions.  
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Next, we hypothesized that heat generation in the muscles, 𝑃𝑚, at given running speed is 
independent of the ambient temperature. Figure ‎4.3 C represents the 𝑃𝑚 estimates for 0, 6, 12, 
and 18 m/min speed of treadmills at both values of  𝑇𝑎 .  There is no statistically significant 
difference between values for matching speeds, which is compatible with the above idea.  
Using these two restrictions provided more precise estimates of the model parameters (compare 
Figure ‎4.3 B and C with Figure ‎4.3 D and E). This allowed us to conclude that the heat generated 
by the muscles increases with the speed, but this increase saturates as speed is increased. As soon 
as we used the 𝑃𝑚  estimates obtained by fixing 𝑃0 = 0 for the models with the high ambient 
temperature (𝑇𝑎 = 32 °𝐶) as priors for the model with the ambient temperature 𝑇𝑎 = 25°𝐶, we 
were able to calculate changes in the core heat production at 𝑇𝑎 = 25°𝐶  with much better 
accuracy (Figure ‎4.3 E). Again the compensatory decrease in the core heat generation appeared 
statistically significant even when the animal was placed on the idle treadmill, and saturated at 
the speed of 12 m/min. 
4.5.10 Role of heat dissipation 
There are two ways in which the net heat accumulation 𝑃0 can be decreased by exercise. It can 
be due to suppression of thermogenesis, which is used to keep body temperature constant in 
relatively cold environment, or it can occur through increased heat dissipation. The major 
mechanism responsible for controlling heat dissipation in mammals is cutaneous blood flow. 
Cordeiro et al. [95] recorded the body temperature of rats running at 18 m/min at 5% incline 
simultaneously with the tail temperature — a marker of heat dissipation. The tail temperature 
reached its maximum at approximately 20 minutes, and this moment corresponded to the 
beginning of plateau phase of body temperature at approximately 38.5
o
C. The experimental set 
up for our study with the highest speed was the same except we did not impose the incline. 
Running time in our experiment was 15 min, and we did not observe plateauing of the body 
temperature. Hasegawa et al.[86] also confirmed that at body temperatures below 38
o
C, the tail is 
not dissipating heat effectively. Cutaneous heat loss threshold temperature in running rats is at or 
above 38.5
o
C in other studies as well [96, 97]. Tanaka et al [87] also demonstrated that the 
threshold for cutaneous vasodilation increases with increasing speeds and exceeded 39
o
C when 
running required above 70% of maximal VO2 consumption, which approximately corresponds to 
the maximal running speed in our experiments [98]. This let us consider that at least for most of 
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the experimental time we did not reach conditions for significant cutaneous vasodilation 
resulting in noticeable additional heat loss. As a result, the changes in 𝑃0 account for alterations 
in the thermoregulatory heat generation.  
4.6 Biological implications 
4.6.1 Outline 
In this study we quantitatively describe a particular thermoregulatory mechanism concerned with 
partial compensation of heat overproduction during exercise. This mechanism is based on the 
reduction of regulatory thermogenesis. We hypothesize that the impairments of this mechanism 
may lead to faster overheating and hence may underlie heat injury/stroke in some cases.  
For example, heat illness is typically observed in individuals exercising in hot environment. 
However, there are multiple occasions when it affects competitors in events in moderate climate, 
when majority of participants appears to be not prone to this medical condition. Surprisingly, the 
correlation with running speed is often significant but fails to reliably explain more than a 
fraction of the variability in body temperatures [99, 100]. In modeling terms it means that high 
body temperature is not a direct consequence of extreme amounts of heat due to the intensity of 
running. Less effective suppression of baseline thermoregulatory heat production could be one of 
mechanisms which results in overheating in some athletes. 
4.6.2 Are changes in metabolism specific to exercise? 
One could interpret the increase in body temperature at the idle belt as a stress response, which 
remains despite rat familiarization to running on a treadmill. However, one can also notice that 
this increase is a part of a pattern: the core heat production drops while the heat production in 
muscles increases. The same phenomenon was observed in rats that were actually running. This 
allows formulating a hypothesis that muscular metabolic engagement and a compensatory 
decrease in the core heat production are not a response to exercise per se, but an anticipatory 
response to the need to run. In some situations this demand may never actualize (when the speed 
is 0).  
Can we distinguish between anticipation of exercise and stress? The very definition of general 
adaptation syndrome by Selye as “a generalized effort of the organism to adapt itself to new 
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conditions”  [101], suggests that reactions to exercise could be considered as responses to stress. 
Noteworthy, stress is typically associated with locomotion, and helps to prime the organism for 
fight-or-flight [102].   
4.6.3 Temperature of muscles as a critical physiological end-point 
It is difficult to measure muscle temperature in humans and animals while they are exercising 
without negatively affecting their ability to run. In those experiments where researchers placed 
temperature probes adjacent to muscles of exercising animals [77], similar values to what we 
predict (Figure ‎4.5) were observed (39oC adjacent to muscles after 15 min at 9 m/min in [77] vs 
39.5
o
C in the muscle after same time at 12 m/min in our model at room temperature).  
Our modeling shows that the temperature in muscles when running with the fastest speed, 18 
m/min, reaches 41
o
C and approach the levels (41-42
o
C) at which the muscle tissue can be 
damaged [103]. Avoiding this damage is important for selection of appropriate training regimens, 
especially in highly competitive athletes. Modeling may serve as an effective tool to determine if 
specific exercise regimens and conditions can result in thermal injury. 
4.6.4 Energy production as a marker of substrate utilization 
Heat production is a measure of substrate utilization during exercise, and as such is directly 
linked to weight loss induced by exercise. Therefore, knowing heat production during exercise is 
important from public health viewpoint. The finding that energy expenditure is relatively 
independent of the exercise load could have quite far-reaching considerations for fitness 
practitioners. In our experimental conditions, most important factor associated with calorie 
expenditure was that exercise was occurring; the intensity of the exercise appears to have had a 
minor influence.  
4.7 Conclusions 
Our study serves as a step towards a comprehensive mathematical model of the thermoregulation 
during exercise. Inclusion of both thermogenesis and heat dissipation together with 
corresponding control mechanisms are needed to predict adverse temperature in exercising 
individuals. In this paper we have studied in rodents an “Activity for free” phenomenon [74], 
which is a significant thermoregulatory mechanism activated by exercise. The phenomenon is 
70 
 
relatively obvious biologically – when additional heat is produced by exercise, the generation of 
heat aimed at maintaining body temperature can be reduced.  The energy which was used for 
maintaining body temperature is now used for locomotion (thus the name “Activity for free”). 
However, for the first time we had characterized this phenomenon quantitatively. At room 
temperature, rats are able to save from a quarter to a half of energy used for running. This 
compensatory suppression of metabolism is quickly saturating with the load. At running speeds 
as low as 12 m/min with zero incline the drop of metabolic activity in the core is already 
maximal. We predict that in colder conditions, which induce significant levels of metabolic 
support for homeothermy, this compensation could be more substantial. 
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 AMPHETAMINE ENHANCES ENDURANCE BY CHAPTER 5.
INCREASING HEAT DISSIPATION 
5.1 Introduction 
In many conditions exhaustion may serve as an important safety mechanism keeping the 
organism from irreversible damage caused by intense exercise [104]. It was previously shown 
that low to moderate doses of amphetamine increase the time until exhaustion in exercising rats 
[105, 106]. Although amphetamine usage is prohibited during competitions, it may be used in 
some situations to improve performance by delaying exhaustion [107]. However, the mechanism 
by which amphetamine increases the time to exhaustion is unknown. 
High body temperature is one of the strongest exhaustion signals [108]. During exercise, the 
temperature of the muscles as well as the core body temperature is elevated as a consequence of 
increased heat production in the muscles. To limit the temperature growth, regulatory heat 
dissipation mechanisms, e.g. vasodilatation and evaporative cooling through saliva spreading in 
rodents or sweating in humans, are engaged to help remove heat during physical exercise [109, 
110].  The balance between heat production and heat dissipation is crucial for keeping the 
temperature of different compartments of the body in a safe range.  
Amphetamine is known to affect the thermoregulatory system [111] by altering both heat 
production and heat dissipation. It has been previously shown that amphetamine increases the 
temperature at which exhaustion occurs at a high ambient temperature, producing a risk of 
developing exertional heat stroke [98]. Production of large amounts of heat by the muscles 
during exercise results in muscle tissue temperature being higher than core temperature. Muscle 
tissue itself can be damaged if its temperature becomes too high [103]. Damage to the myocytes 
releases the content of the cells into the circulation. Misbalance of electrolytes can lead to 
cardiac arrhythmias, while a release of myoglobin may cause renal failure [112]. Unfortunately, 
thermal or biochemical damage to the myocytes is not usually detected until post exercise. 
Therefore, any alterations in the thermoregulatory system that lead to higher muscle 
temperatures can be extremely dangerous. 
In this study we aimed to find how amphetamine affects the mechanisms of exhaustion in 
exercising rats. To do so, we collected experimental data on heat production and the core 
temperature in rats running on a treadmill, and calculated the unobserved parameters, such as 
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muscle temperature and heat dissipation, using our previously published mathematical model 
[4].This approach helped us to identify a novel and counterintuitive mechanism underlying 
ergogenic effect of amphetamine, as well as provided new arguments on potential danger of 
using psychostimulants to improve performance during exercise.   
5.2 Methods and Data Preparation 
5.2.1 Experimental design 
On the day of experiment rats were brought to the experimental room and allowed to adapt to the 
experimental condition. Telemetric recording of body temperature was initiated. After at least 30 
minutes of baseline recording, the animal was administered with amphetamine or saline 
intraperitoneally according to the protocol. Immediately after the injection, animals were placed 
on a belt of the treadmill, and gas analysis was initiated. After 12 minutes, the treadmill was 
activated with the intensity of exercise increased every 3 minutes according to the experimental 
protocol (Figure ‎5.1).  
 
 
Figure ‎5.1 The experimental protocol: (A) Speed and (B) incline of the treadmill. Rats 
were injected with amphetamine or saline 12 min before the treadmill belt was activated. 
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Figure ‎5.2 Changes in the core body temperature and heat production in rats running on a 
treadmill after 1 mg/kg of amphetamine. A. The body temperature after saline injection 
(dashed line), or amphetamine injection (solid line). Error bars represent standard 
deviations over a group of rats. B. Heat production calculated from O2 consumption and 
CO2 production. 
5.2.2 Data analysis and statistical procedures 
We calculated the average and the standard deviations of the core body temperatures and 𝑉𝑂2 for 
all groups. Considering that the dose of 1 mg/kg of amphetamine did not affect body temperature 
with statistical significance, for modeling purposes we only used data for the control group 
(injected with saline) and amphetamine group which received 2 mg/kg of amphetamine. In order 
to obtain consistent datasets, we discarded data points starting when at least one of the rats in 
each group dropped out. Thus, the experimental data from t = -12 min  to t = 13 min for saline 
(n=6), and from 𝑡 = −12 min to t = 15 min for amphetamine (n=6) was used for estimating 
model parameters. So, we used {𝑇𝑘(𝑡)}𝑡=−12
𝑁  as the set of data points for k
th
 group (where k = 
saline or Amph) and N=13 or 15 for saline and Amph, respectively. The initial 𝑉𝑂2 level was 
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measured after the calibration time of the instrument. The level was steady before the running 
started. Accordingly, we considered 𝑂2 consumption constant from -12 min to 0 min for each 
group and equal to the mean value of 𝑉𝑂2 at t = 0 min. The experimental data used for the model 
calibration are shown in Figure ‎5.3.  
Between-group comparison of heat dissipation and heat production was performed using z-test. 
Statistical significance was defined as a p-value <0.05. Values are presented as mean ± SE. 
 
 
Figure ‎5.3 Changes in the core body temperature and heat production in rats running on a 
treadmill after 2 mg/kg of amphetamine. A. The body temperature after saline injection 
(dashed line), or amphetamine injection (solid line). Error bars represent standard 
deviations over a group of rats. B. Heat production calculated from O2 consumption and 
CO2 production. For modeling purposes, the heat production was assumed to be constant 
before the start of run (horizontal dashed lines). 
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5.3 Model Construction 
5.3.1 General Model 
In order to quantify heat generation and heat loss in all groups, we adapted a mathematical model 
describing the temperature changes in two compartments, representing the core and the muscles 
[4]. In the model, the heat production parameter in the core, 𝑃𝑐, is defined as total heat generated 
in the core body per time unit divided by the heat capacity of the core. Similarly, the heat 
production in the muscles, 𝑃𝑚, is extra heat generated in the muscles by physical activity per time 
unit divided by heat capacity of the muscles. Both parameters have units of °𝐶/𝑚𝑖𝑛 . The 
muscles exchange heat with the core proportionally to the heat transfer coefficient 𝜂  and the 
difference between temperatures of two compartments (𝑇𝑐 − 𝑇𝑚). The value of 𝜂 was fixed at 
0.125 min
-1
 based on [4]. Heat exchange between the core and environment is proportional to 
another heat transfer coefficient 𝜂𝑎  and the difference of temperatures between the core and 
environment, (𝑇𝑐 − 𝑇𝑎) . Therefore, changes in the core and the muscle temperatures are 
described by a system of two first-order differential equations: 
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 (‎5.1) 
 
As noted, the heat production and the heat dissipation parameters in this model have units of  
°𝐶/𝑚𝑖𝑛. However, they can be easily converted into units of power (Joules/min) by multiplying 
by the heat capacity (in Joules/°𝐶) of the corresponding compartment [79].  
In accordance with experimental data in [77] we assumed that at the beginning of the experiment 
(prior to the run) the temperature of the muscles was equal to the temperature of the core.  
Specifically, 𝑇𝑐  and 𝑇𝑚  are the same at 𝑡 = −12  min when each rat was just placed on a 
treadmill after an injection: the initial conditions are
 0
)12()12( TTT cm  . Initial temperature 
for each group was calculated as the averaged core body temperature from 𝑡 = −15 min to 
𝑡 = −12 min.  
Almost all the energy generated in the body is due to oxidation. Total energy production in the 
body is proportional to the amount of consumed oxygen, 𝑉𝑂2 (liter per kg). Some portion of the 
energy is spent for the mechanical work (MW, cal/kg/min), and the rest is transformed to the heat. 
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Accordingly, after denoting the coefficient of proportionality between total energy production 
and oxygen consumption by  , for the total heat production we have: 
 ))()(( 2 MWtVOmmPmPm cmccmm    (‎5.2) 
 
Here 𝑚𝑚 and 𝑚𝑐 are heat capacities of the muscles and the core, respectively, and 𝑚𝑚 + 𝑚𝑐 is a 
total heat capacity of a rat. Taking into account that the skeletal muscle mass of a rat constitutes 
approximately 45-50% of its body weight [75] with the mass of a skeleton constituting only 
about 3%, we set  𝑚𝑚 = 𝑚𝑐 in the model. Accordingly, the above equation reduces to the form 
of: 
 ))((2 2 MWtVOPP cm    (‎5.3) 
 
The coefficient 𝛼 can be calculated as calorific value (CV) divided by the specific heat of the 
body. The latter for a rat is approximately 0.8 kcal/(kg·ºC) [79]. CV is calculated as: 
 RERCV 232.1815.3  (kcal/liter) (‎5.4) 
 
where RER stands for the respiratory exchange ratio, which is the ratio of the carbon dioxide 
production (𝑉𝐶𝑂2) to the oxygen consumption (𝑉𝑂2) [81]. 
The mechanical work consists in climbing the treadmill at the given speed (m/min) and incline (°) 
(see Figure ‎5.1) and can be estimated as 184.4/)tan(inclinespeedgMW   in cal/kg/min, 
where g=9.8 m/s
2
 is gravitational acceleration. 
5.3.2 Model Parameters Estimation 
Since 𝑉𝑂2 and 𝑉𝐶𝑂2  were measured, once we determine 𝑃𝑐 , then 𝑃𝑚  can be calculated using 
(‎5.3). Accordingly, model (‎5.1) has two undetermined independent parameters, 𝑃𝑐 and 𝜂𝑎. We 
used Bayesian approach to find statistical distributions for these parameters. Specifically, for 
each group k, measured core temperature values {𝑇𝑘(𝑡)}𝑡=−12
𝑁  were considered independent 
normal random variables with the mean values 𝑇𝑐(𝜂𝑎, 𝑃𝑐 , 𝑡) (solution of (‎5.1)), and standard 
deviations 𝜎𝑘(𝑡) calculated from experimental data. Based on this assumption, the likelihood 
(conditional joint probability density function) was calculated: 
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where 𝑘 = Saline or Amph, and 𝑁 = 13 or 15 for Saline and Amph, respectively. The likelihood 
(‎5.5) was sampled using Markov Chain Monte Carlo approach by Metropolis-Hastings algorithm 
[1, 51-53, 67, 78]. 
5.4 Results 
5.4.1 Experimental Data 
Baseline core body temperature of all rats was uniform in the range of 37.5 ± 0.3 °𝐶. As soon as 
rats were placed on a treadmill, their body temperature dropped slightly (Figure ‎5.2 and 
Figure ‎5.3, from -12 min to -10 min,). The presence of a “hypothermic” phase is related to the 
decrease in core heat production in physiologic “anticipation” of/during exercise, which was 
described by us earlier [4]. Eventually, the body temperatures of rats in all groups started rising. 
Low dose of amphetamine (1 mg/kg, i.p.) significantly affected neither body temperature, nor 
oxygen consumption at any time point (Figure ‎5.2). Similarly, there was no effect of this dose on 
the body temperature at the time of exhaustion. In contrast, higher dose of amphetamine (2 
mg/kg) had significant effects on both temperature dynamics and exhaustion time. The 
amphetamine injected group had lower core body temperature than the saline group throughout 
the experiment (Figure ‎5.3 A). Amphetamine also significantly changed the dynamics of 
temperature: in rats treated with saline the temperature increased at a steady rate, while 
temperature increase in the amphetamine group was significantly slower in the beginning of the 
run (Figure ‎5.3 A).  Compared to controls, amphetamine extended the time to exhaustion: 17.3 ± 
0.6 min vs 14.8 ± 0.8 (p < 0.05). Interestingly, the temperature at exhaustion was not 
significantly different between the groups (40.0 ± 0.2 after amphetamine vs 39.9 ± 0.2 after 
saline, p > 0.05). 
The effect of amphetamine on body temperature during running had no correlation with VO2 
consumption. For all matching workloads there was no significant difference in VO2 
consumption between rats which received amphetamine or saline (Figure ‎5.3B). However, longer 
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runs and, hence, higher workloads after amphetamine were accompanied by a higher maximal 
VO2 at the end of run (VO2max).  
 
 
Figure ‎5.4 Model parameter estimates: A. Statistical ensembles of parameters Pc (heat 
production in the core) and a

 (heat exchange between the core and the environment) for 
saline (crosses) and amphetamine (open circles) generated by Markov Chain Monte-
Carlo sampling (see text for details). Mean values and standard errors of Pc (B) and a

 
(C) for saline and amphetamine groups.  * - statistically significant difference (p<0.05). 
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5.4.2 Amphetamine increases heat dissipation 
Slower core body temperature increase in the Amph group can be explained either by an increase 
in heat dissipation, i.e. an increase in 𝜂𝑎, or by a decrease in heat accumulation at the core body, 
i.e. a decrease in 𝑃𝑐  (see (‎5.1)). We estimated these parameters, 𝑃𝑐  and 𝜂𝑎 , by fitting the 
mathematical model (‎5.1), (‎5.3) to the experimental data shown in Figure ‎5.3A.  Figure ‎5.4A 
contains ensembles of parameters (𝑃𝑐, 𝜂𝑎) distributed according to the corresponding posterior 
probability density functions (likelihoods, see Methods). These ensembles were generated by 
Markov Chain Monte-Carlo method as described in Methods. Statistical analysis of these 
samples showed that the heat production in the core body (𝑃𝑐) was not significantly different 
between the groups: 0.25 ± 0.02 
o
C/min after saline vs 0.24 ± 0.02 
o
C/min after amphetamine 
(Figure ‎5.4B). In contrast, the heat dissipation coefficient for the Amph group (0.0194 ± 0.0005 
min
-1
) was significantly higher (p<0.005) than heat dissipation in the saline group (0.0156 ± 
0.0005 min
-1
) (Figure ‎5.4C). For each group, we fitted the core body temperature dynamics 
based on the total heat production in the body (from VO2), as well as we sampled values of heat 
production in the core, 𝑃𝑐, and heat dissipation, 𝜂𝑎. As shown in Figure ‎5.5A, at most probable 
values of 𝑃𝑐 and 𝜂𝑎  (best fit), the model reproduced the core temperature dynamics after both 
saline and amphetamine within one standard deviation. 
5.4.3 Muscle temperature reaches higher levels in amphetamine treated rats 
Using Eq. (‎5.3), we calculated the heat production by muscles 𝑃𝑚 , and then estimated the 
temperature of the muscles by plugging sampled values of parameters (𝑃𝑐, 𝜂𝑎), shown on the Fig. 
4, to Eq. (‎5.3). Throughout the run, the muscle temperature in the saline group was slightly 
higher than in the Amph group. However, the difference in muscle temperature between the two 
groups was dramatically smaller that the difference of core body temperatures. Due to the fact 
that after amphetamine, rats were able to run almost 3 minutes longer than control rats, the 
muscle temperature at the end of the run in the Amph group reached values that were 
significantly higher than in the saline group. The highest muscle temperatures at the end of run 
after saline and amphetamine were estimated as 41.2 ± 0.1 
o
C and 41.9 ± 0.2 
o
C, respectively 
(Figure ‎5.5B). 
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Figure ‎5.5 Comparison of experimental data and model performance, and calculated 
temperature of the muscles: A. Calculated core body temperature of rats injected with 
saline (dashed line) or amphetamine (solid line) together with the experimental data 
(shown by error bars representing the mean +/- standard deviation). Dashed vertical lines 
show the beginning of running (t=0) and the average time of exhaustion in two groups. B. 
Calculated muscle temperature dynamics for the two groups. Error bars represent standard 
errors. * - statistically significant difference (p<0.05). 
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5.5 Discussions 
5.5.1 Overview 
Amphetamine at low to moderate doses enhances physical performance of humans and animals 
[105, 106, 114]. We observed that relatively low dose of amphetamine (2 mg/kg) increases time 
to exhaustion in rats exercising with high intensity (high speed treadmill running) at room 
temperature. This dose of amphetamine is similar to those that animals self-administer [115, 116] 
and comparable to a typical dose that humans use (~50mg). Our observations are in line with 
previous studies showing enhanced endurance in rodents treated with amphetamine [106, 117, 
118]. In this study we provide a novel potential mechanistic interpretation of this phenomenon; 
we show that amphetamine increases heat dissipation which helps the core body temperature to 
delay reaching the threshold for exhaustion. 
Considering that well-controlled body temperature is one of the determinants of endurance, the 
goal of the present study was to evaluate the effect of amphetamine on the thermoregulatory 
system in rats running on a treadmill. We applied mathematical modeling to explain the 
amphetamine-induced changes of the body temperature dynamics in running rats. This approach 
allowed us to calculate parameters that are difficult to measure experimentally, i.e. heat 
dissipation coefficient, heat production in the core and the muscles, and muscle temperature. 
Proper functioning of thermoregulatory system plays an important role in ones’ ability to 
maintain particular levels of physical activity. Excessively high body temperature can cause (or 
underlie) exhaustion and limit exercise duration. Walters at el. [119] and Fuller at el. [120] 
provided evidence of the existence of a limiting body temperature; they showed that at a point of 
exhaustion from voluntary running on a treadmill, the abdominal and the hypothalamic 
temperatures reached certain thresholds. Moreover, the limiting temperatures were independent 
of ambient (𝑇𝑎) and initial (𝑇0) temperatures. In agreement with these experimental observations, 
the core body temperatures of rats at the end of running due to exhaustion were not statistically 
different between Amph and saline groups in our study (Figure ‎5.3A). However, at any time 
point during the run the core body temperature of rats treated with amphetamine remained 
significantly lower than of control rats. This strongly suggests that Amphetamine delayed 
temperature rise to the critical value at which exhaustion occurred and, as the result, significantly 
increased the time to exhaustion. 
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Based on VO2 and VCO2 measurements we calculated the total heat production in both groups. 
We found no significant difference in heat production during running between the groups, 
meaning that changes in temperature dynamics are caused either by redistribution of heat 
production in the body, or by an increase in heat dissipation. To discriminate between these two 
possibilities, we used a mathematical model (‎5.1), (‎5.3) describing temperature changes in the 
core and muscle compartments during run. For this purpose we adapted the model from [4]. 
Previously, for simplicity, heat dissipation to the environment and heat production in the core 
were combined in a single term: overall net heat production in the core. We augmented that 
model by incorporating heat production in the core and heat dissipation to the environment 
explicitly. This improvement allowed us to use experimental data to estimate heat dissipation 
coefficient (𝜂𝑎)  and heat production parameter (𝑃𝑐),  and then to infer which parameter is 
affected by amphetamine. We found that amphetamine significantly enhances heat dissipation 
and has no effect on heat production. 
While the rise of 𝑇𝑐 was slowed down by increased heat dissipation, the cooler core was not able 
to significantly delay the rise of 𝑇𝑚. Therefore, at any selected time the muscle temperature was 
not significantly different between Amph and Saline group. However, due to increased running 
time in Amph group, the muscle temperature in this group was significantly higher at the end of 
running (Figure ‎5.5). This difference of almost 1ºC brings the temperature of muscles to the level 
that could result in physical damage of muscle tissue from hyperthermia.  
Based on the above, we can hypothesize that exertional exhaustion may be mediated by failure of 
thermoregulatory mechanisms to keep the core body temperature below the threshold. The same 
mechanism indirectly allows keeping the temperature of contracting muscles within safe range. 
Administration of psychostimulants does not change the threshold for the core temperature at 
room temperature. However, it tricks the thermoregulatory system by an “unauthorized” increase 
of heat dissipation and, thus, increasing the gap between the temperatures of the core and the 
muscles, which may be potentially dangerous for the latter. 
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5.5.2 Model assumptions 
We considered the heat dissipation coefficient 𝜂𝑎  constant throughout the exercise. This 
assumption is based on the following logic. Major changes of heat dissipation in running rats 
occur when thermoregulatory mechanisms dilate cutaneous vessels. Tail temperature is a well-
accepted marker of thermoregulatory heat dissipation. [87] measured the body temperature and 
the tail temperature in rats running with various speeds at room temperature. The threshold 
temperature for heat dissipation (body temperature at which heat dissipation starts increasing) 
quickly rises with the increasing work intensity and at the highest workloads it reaches a 
maximum value of 39.3 °𝐶. Therefore, in the beginning of our experimental protocol, the body 
temperature was too low for cutaneous vasodilation to occur. Later on, the body temperature 
increased, but so did the workload. As a result, according to [87], the heat loss threshold would 
not be hit before the core body temperature reached levels of approximately 39 °𝐶 . In our 
experiments, the highest 𝑇𝑐  values at the end of the analyzed period were 39.6 °𝐶  for Saline 
group and 39.4 °𝐶   for Amph group. Therefore, it was reasonable to consider that the heat 
dissipation did not change within the interval used for model calibration. 
Also, when cutaneous vasodilation finally kicks in, body temperature in running animals stops 
rising and in most cases plateaus [87]. In our recordings we did not observe any instances of 
temperature plateauing before animals stopped running, which also confirms that the threshold of 
thermoregulatory changes in heat dissipation was not reached. This allowed us to assume that the 
heat dissipation coefficient was constant throughout the exercise.  
5.5.3 Amphetamine increases VO2max by slowing the temperature rise 
Our data show that amphetamine per se does not significantly affect oxygen consumption (VO2) 
at the same exercise intensity. VO2max in the amphetamine group is increased because rats 
injected with amphetamine can run for longer times thus undergoing a higher physical load 
according to the protocol. The important implication of our study is that due to higher heat 
dissipation, it takes longer for the temperature of amphetamine-treated rats to reach the threshold 
for exhaustion. This is why they continue to run at higher speeds/inclines, and, thus, exhibit 
higher VO2max at the end of the run. Accordingly, higher VO2max in the amphetamine group is 
indirectly caused by higher heat dissipation. 
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5.5.4 Amphetamine increases heat dissipation, but does not suppress thermogenesis 
Our modeling results show that a relatively low dose of amphetamine (2 mg/kg) increases heat 
dissipation, which in turn slows down the core body temperature rise. This finding was made 
possible by simultaneous measurements of the core body temperature and energy expenditure. 
Core body temperature was significantly lower in the amphetamine group, while energy 
expenditure was no different between the groups, meaning that total thermogenesis was not 
affected by amphetamine. Using mathematical modeling we were able to answer the question 
whether amphetamine redistributes heat generation between body compartments, or it affects 
heat removal from the body. We found that amphetamine increases heat dissipation from the 
core, while its effect on heat production is significant neither in the core nor in the muscles. As a 
direct experimental validation of our result, whole body calorimetry could be used. 
Spreading of saliva, which is one of heat dissipation control mechanism in rats, is difficult to 
employ while running. Water evaporation from the respiratory tract, which is increased during 
the exercise [87] due to increased ventilation and higher body temperature is dictated by energy 
demand rather than thermoregulation. Therefore, rats control their heat exchange with the 
environment during exercise predominantly by dilating or constricting cutaneous blood vessels. 
Due to absence of fur and large surface area, the tail is the major thermoregulatory organ in rats.  
More than forty years ago, [111] measured the tail temperature of rats after treatment with 
various doses of amphetamine. They reported an amphetamine-induced dose-dependent decrease 
in tail temperature, suggesting that amphetamine induces cutaneous vasoconstriction and, thus, 
decrease in heat dissipation. Considering that hyperthermia induced by amphetamine or its 
derivatives is one of the major complications and may be life-threatening [121, 122], an increase 
in heat dissipation coefficient found in this study is counterintuitive. Nevertheless, using a simple 
mathematical model, we directly linked heat production (based on oxygen consumption) and 
body temperature increase (characterizing the retained heat), which allowed for reliable 
estimation of the heat produced and dissipated. Our estimates unequivocally show a significant 
increase in heat dissipation coefficient after amphetamine administration and no evidence of 
altered heat production.  
One of possible explanations of the seeming discrepancy is that profound hyperthermia is 
associated with higher doses (5 mg/kg and above), while we studied relatively low doses (1-2 
mg/kg). Our findings may have implications on the mechanistic interpretation of previous 
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experimental results concerned with effects of amphetamine and its derivatives on temperature 
dynamics. Recently Molkov et al. published experimental and modeling data on extremely 
complex dose-dependence of temperature effects of methamphetamine [1]. The interpretation 
was that in doses exceeding 1 mg/kg methamphetamine activated an inhibitory component, 
which reversed effects of excitatory influence of lower doses on heat production. Therefore, the 
aforementioned intricate dose-dependence is a result of delicate balance between activation of 
excitatory and inhibitory pathways controlling heat generation [123], while both components are 
mediated by orexinergic neurotransmission [124]. In that study, based on existing literature data, 
we explicitly assumed that at room temperature amphetamines do not increase heat dissipation; 
an assumption that may require reassessment in light of the findings presented in this study.  
We are not aware of any specific mechanisms that can explain the increase of heat dissipation by 
amphetamine during running. However, we estimated the change of the heat dissipation 
coefficient to be less than 30%. It is dramatically smaller than more than 10-fold range of 
metabolic activity. Assuming that thermoregulatory variations in heat dissipation are comparable 
in magnitude, and that those variations are in significant part mediated by cutaneous vasodilation, 
the inhibitory effect of amphetamine on cutaneous vasoconstriction may be modulatory. For 
example, there is a possibility that activation of alpha2-adrenoreceptors in ventromedial raphe by 
amphetamine could be a culprit [125], which is similar to what Molkov et al. suggested as a 
possible mechanisms of inhibitory component in the thermoregulatory effects of 
methamphetamine [1].  
Tail temperature seems to be a good indicator of the changes in heat dissipation mediated by 
cutaneous vasodilation. However, there are serious limitations on what tail temperature 
measurements can reveal. Tail flow modulation supports changes of heat dissipation in a 
multifold range (100-fold increase of flow), so the change of heat dissipation within 30%, found 
in our study, will not be statistically significantly reflected in the tail temperature. In addition, 
other than vasomotor mechanisms should be considered, e.g. an increase in respiratory 
evaporation or a change of insulating properties of fur. 
Possible mechanistic interpretations do matter for translational importance of our observations, 
as some physiological mechanisms in rodents could be missing in humans and vice versa. 
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5.5.5 Implications for exercise at different ambient temperatures 
An interesting testable prediction provided by our study is that the effect of amphetamine may 
depend on ambient temperature. Since the heat exchange with the environment is proportional to 
the temperature gradient (the difference between the body temperature and the ambient 
temperature), the same change in the heat conductance (heat transfer coefficient in our model) 
would lead to greater variations in total heat loss in colder environments. Accordingly, we expect 
that at higher (lower) ambient temperatures the effect of amphetamine on endurance is weaker 
(stronger) given that the increase in heat conductance is the same. 
5.6 Conclusion 
Using core body temperature dynamics and mathematical modeling, we estimated parameters 
that are hard to measure experimentally, i.e. the distribution of heat production in the core and 
muscles and the heat dissipation coefficient. We found that in rats, amphetamine (2 mg/kg) slows 
down the temperature rise during treadmill exercise at room temperature by increasing heat 
dissipation. We suggest that this psychostimulant increases the time to exhaustion in rats, at least 
in part, by delaying the moment when the core body temperature exceeds the threshold defining 
exhaustion. The calculated muscle temperature at the end of run in rats after amphetamine was 
almost one degree higher than after saline which may be health-threatening. We conclude that 
while amphetamine improves endurance and extends the time at which exhaustion occurs, its use 
can result in health-threatening complications. 
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 CONCLUSION CHAPTER 6.
In this thesis, we used a new mathematical modeling approach to learn insightful information 
about thermoregulation system and how Methamphetamine and Exercise impact its mechanism. 
These findings and learnings can be split into two main categories: Mathematical Modeling 
Developments and New Biological Insights. 
6.1 Mathematical Modeling Developments 
In this thesis, we used a new mathematical modeling approach that was first introduced in [1] as 
the main and base framework. By expanding this model to some case study, we were able to 
explore some of the underlying components of thermoregulation which are impacted by Meth or 
Exercise. Moreover, we measured some of their properties and correlations. For this purpose, we 
used a combination of Neural Network and Bayesian approach which allowed us to calculate the 
statistical significances in changes of these components. Also, we developed reduced models and 
explained uncertainties in our models and discussed their impacts on each component of the 
models. For each model, we tried to make meaningful biological interpretations for when our 
models is perturbed under these uncertainties. Finally, for some hypothetical studies, we were 
able to calculate the changes in our model’s parameters which then allow us to make prediction 
for the future of the system. These predictions were helpful to explain some of the extreme 
reactions of the system that have been reported or can be proven experimentally.  
6.2 New Biological Insights 
In Orexin study, we discovered that both Meth and stress activate the excitatory component and 
evoke temperature response. Also, we explained that the neural circuitry of thermoregulation 
system in our model have meth sensitive components which are mediated by orexin receptors 
and hence can be suppressed by SB. Insufficient inhibitory drive can cause fatal hyperthermia 
after relatively low doses of Meth. 
In Circadian Study, we were the first to measure and compare the body temperature responses in 
rats to injections of Meth during daytime and at night where the temperature changes were much 
weaker than daytime. Using our model, we inferred that during night the baseline activity of the 
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excitatory components are elevated and thus the additional response to the Meth injection is 
weaker during night than similar dose during daytime. We also found that once Meth is washed 
out of the blood, temperature stabilized at lower level that initial temperature.  
Our Exercise study demonstrated that both thermogenesis and heat dissipation together with 
corresponding control mechanisms are critical to quantify the changes in body temperature 
during exercise. We were the first to characterize “Activity for free” phenomenon. Also, we 
predicted that, in colder condition than room temperature, the compensatory suppression of 
metabolism is much greater than half of metabolism. Finally, we discussed that some unusual 
compensatory adjustment in thermoregulation system might be the cause for heat injuries during 
exercise.   
Last but not least, we combined Exercise and Amphetamine to perturb the thermoregulation 
system. We were able to measure the dynamics of heat production and dissipation in the core and 
muscles. We discovered that during exercise at room temperature, injection of Amphetamine (2 
mg/kg) can increase the heat dissipation which results in reduction of the temperature rise. This 
mechanism increases the exhaustion threshold in rats and allows them rats to run longer. 
However, when Amphetamine is injected, the muscle temperature is almost one degree higher at 
the end of running compare to when only Saline is injected. This can result in serious muscle 
injuries and other health threatening conditions.  
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